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Introduction
Switzerland is a country with a strongly decentralized political system, based on federalism and
institutions of direct democracy, on a liberal economic culture, and on a well–developed tradition
of mutualism and social security (generous social expenditure and welfare system). Switzerland
is unique for its high level of decentralization and for the particular distribution of competences
and roles between the central State (the Confederation) and the cantonal authorities. This
particular setting allows cantons to have significant leeway in the organization of health care and
the implementation of specific public policies.
My thesis aims to give a contribution to the health economics literature, assessing some of
the internal implications of the Swiss federal setting in the health care sector (chapters 1 and 2)
and drawing some more general public policy results, exploiting the Swiss context (chapter 3).
The first two chapters explore two different sides of the equity of the Swiss health care system.
In the first chapter, I assess to what extent the political autonomy allocated to cantons leads to
differences in the level of regressivity in the financing of the health care system and over time.
The second chapter investigates the role of managed care contracts and higher deductible on the
equity in health care utilization. Finally, in the third chapter I carry out a policy evaluation
analysis to assess the causal effects of smoking bans on acute myocardial infarction. Different
from the other two chapters, this work draws conclusions that abstract from the Swiss context.
Switzerland is the perfect setting where to employ our empirical strategy, due to the different
times of implementation of the policy if interest. However, the results have external validity.
Each work is based on a different database: the first and the third are based on administrative
data, while the second one relies on survey data.
The first chapter, “The inequity of the Swiss health care system financing from a federal state
perspective” (with Luca Crivelli) focuses on the equity issue in the health care system financing.
It aims to detect differences at the cantonal level. In previous studies the Swiss health care
financing results as particularly regressive. However, the currently available information does
not allow to monitor income-related inequities in financing health care across cantons. This
study aims at filling this information gap exploring the differences and the level of regressivity
in the financing of the health care system across cantons and over time, considering the role of
3
fiscal federalism. In the first part of the study, I describe the different strategies adopted by the
cantons to finance health care, looking at how much financing relies on private resources and
how much on public ones. In the second part, I use the Kakwani index as a summary measure of
regressivity. I compute it for each canton and for each of the sources that have a role in financing
the health care system, i.e. the taxes, both at federal (including VAT) and cantonal level, the
net premiums (after subtracting possible subsidies), and other social contributions. I graph
concentration curves and perform relative dominance tests, which utilize the full distribution
of expenditures. The microdata comes from the “Swiss Household Income and Expenditure
Survey” based on a sample of the Swiss population (about 3500 households per year), for the
years 1998–2005. The empirical evidence confirms that the Swiss health care system financing
has remained quite regressive since the major reform of 1996 and shows that the variations
in equity across cantons are quite significant: the difference between the most and the least
regressive canton is about the same as between two extremely different financing systems like
the US and Sweden. There is no evidence, however, of a clear evolution of regressivity over time.
The significant variation in equity across cantons can be explained by fiscal federalism and the
related autonomy in the design of tax and social policies. In particular, the results highlight that
earmarked subsidies, the policy adopted to smooth the regressivity of the premiums, appear to
be not enough.
The second chapter, “Equity in the Swiss health care system: the role of managed care and
higher deductible”, investigates on a different side of equity: the equity in the access to health
care services. The goal of this study is to analyze empirically the impact that alternatives forms
of insurance, namely managed care and higher deductible, may have on the equity in health
care utilization. I compute concentration indices for the distribution of visits to GP and to the
specialist for the years 2007 and 2012. I use the two last waves of the “Swiss Health Survey”,
a specific survey addressing health issues on a sample of the Swiss population (about 20000
individuals per wave). I compute the need–standardized level of health care for the total number
of visits, for the probability to see a doctor and for the conditional number of visits. The results
suggest not only that specialist visits are pro–rich distributed, in line with previous literature,
but also that the pro–rich inequity worsened over time. By contrast, no pro–rich inequity emerges
in GP visits. I also perform a decomposition analysis (on the total probability of a specialist
visit), to disentangle the contribution of each source of inequity. The findings suggest that the
choice of a higher deductible acts as an entrance barrier for insured, as expected. Nevertheless,
being this option more widespread among the better–off, this barrier prevents from going to the
specialist more people belonging to the middle–rich income class. This study reveals that a high
deductible seems to have two positive effects. First, it rebalances the concentration of visits
towards a smaller pro–rich inequity and second, it discourages moral hazard behaviors. On the
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contrary, the analysis does not find any contribution to inequality due to being enrolled in a
managed care plan, neither in 2007, or 2012.
In the third chapter, “Short terms effects of public smoking bans oh health” (with Fabrizio
Mazzonna) I perform an empirical application aimed at assessing the causal effect of the public
smoking bans on a health outcome, namely the acute myocardial infarction (AMI). Since a
reduction in the AMI cases should be quantifiable immediately after the introduction of the
smoking ban, focusing on AMI allows to measure the short-run effects of the policy on an objective
metrics of health. I use a quasi-experiment, consisting in the fact that cantonal authorities
implemented the same policies in different times, as allowed by the Swiss federalism. I exploit
time and geographical variation in the implementation of the policy to provide evidence of a
causal association between the policy and the health outcome of interest. Data come from the
“Medical Statistics of Hospitals” a wide dataset that collects information on every patient for
every Swiss hospital from 1999 to 2012, provided by the Swiss Federal Statistical Office. The
results suggest that the effect of smoking ban globally reduced the number of AMI of about
7.5–10% percentage points. The effect seems to be stronger for men between 50 and 65 years
old, showing a reduction in the number of AMI of about 15%, and for women over 66. Results
are robust to alternative model specifications. The advantage of focusing on smoking bans is
twofold. On one hand, it allows us to assess a causal relation of smoking (both active and second-
hand smoke) on short-run health effects. On the other hand, assessing the efficacy of this policy
measure on health outcomes offers an interesting contribution in the debate on the effectiveness
of smoking bans on health.
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The inequity of the Swiss health care
system financing from a federal state
perspective
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1.1 Introduction
The idea that health-care services should be paid for according to the ability to pay rather than
according to the actual use of the health-care system finds its roots in the egalitarian concept of
social justice and is generally adopted in Switzerland, as it is in most of the OECD countries. It
is common in the economic literature to indicate this idea using the concept of equity in financing
(Wagstaff et al., 1989). This principle implies not only a form of solidarity between the sick and
the healthy, which is implicit in any health insurance system, but also solidarity between rich
and poor. In this context, two measures of equity exist. The first is “horizontal equity”, which
claims equal treatments for equals; i.e., that people with the same income have to contribute
the same amount of money to the total expenditures. The second measure is “vertical equity”,
which states that people with different income must contribute appropriate amounts to the total
expenditure.
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All of the empirical studies on this topic measure the equity of a financing source in terms
of progressivity; i.e., the extent to which higher-income people pay more as a proportion of their
income than lower- income people.
When the new Health Insurance Act (HIA) came into force in 1996, many things changed
in the Swiss health-care system. The main objectives of the act were to guarantee universal
coverage, to establish a fair competition among health insurers and to equip the political system
with better cost containment tools. Moreover, it also increased the importance of the financing
equity aim: one of the objectives of the reform was to provide monetary assistance to low-income
households in order to increase equity of financing. In the federal draft bill issued in the year 1991
(and approved some years later after many amendments as HIA) we can read that: The main
priority of the project is undoubtedly the strengthening of solidarity. The current law provides for
individual premiums to be paid without taking into account the economic situation of the people
insured (p.67). In order to make this payment affordable for all citizens, the new law replaced the
historically grown system of general state transfers to health insurance with a better endowed
and more equitable system of allowances targeted to low-income households.
At present the health insurance in Switzerland is mandatory for every citizen, and it is
based on community-rated premiums. The confederation jointly with cantons assigns a budget
cap for earmarked subsidies targeting low-income households. Cantons have a great autonomy
in deciding the distribution of subsidies; despite their role of mitigating vertical inequity, the
heterogeneity of cantonal subsidy policies leads to a different treatment of similar households
across cantons (horizontal inequity). As subsidies vary with cantons, people with the same
income living in different cantons may pay a different amount of money for health care.
Some studies have demonstrated that the general level of health system financing is regressive
in Switzerland, both before and after the reform (Bilger, 2008; Wagstaff et al., 1999). This means
that lower-income people pay more as a proportion of their income than higher-income people.
Nevertheless, these studies consider only the whole of Switzerland and no research has mon-
itored the situation at the cantonal level. Due to the Swiss federal setting, each canton differs
in the economic strategy it has adopted to finance the health care system; this leads to different
levels of equity among them. The OECD Review of the Swiss Health System (OECD/WHO,
2011) considers the development of an information system able to monitor this inter-cantonal
variation as one of the Swiss policy challenges for the future.
This paper aims to fill this information gap by analyzing the level of equity in the financing
of the health-care system in the Swiss cantons. In this study we have used the methodology
suggested by Wagstaff and Van Doorslaer (1992) to compute the regressivity level of each canton
through the Kakwani index (Kakwani, 1977). The paper is organized as follows. The next section
presents a review of the most relevant literature in this field. We have collected and summarized
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similar studies conducted for other countries, as well as for all of Switzerland. Section 1.3 provides
a brief explanation of Swiss health system financing. Section 1.4 introduces the dataset, section
1.5 explains the methodology used and section 1.6 the results obtained. Section 1.7 discusses the
results in more detail and outlines the limitations of the study. Finally, section 1.8 offers some
conclusions.
1.2 Literature review
This work finds its place among the studies about the equity of health-care system financing.
Table 1.1 includes the main papers that have been published on this topic. Some of them
have focused on a single country - namely Australia, Iran, Finland, Italy, the Netherlands,
Malaysia, Palestine, Ireland, Tanzania, Ghana, Sweden, and Switzerland. Two papers present
an international comparison, based on 13 Asian countries and 13 OECD countries, respectively.
Table 1.1: Main papers about equity in the health-care financing system
Country Author(s) and year
Italy Paci et al. (1993)
Australia Lairson et al. (1995)
The Netherlands Wagstaff and van Doorslaer (1997)
Finland Klavus (1998, 2001)
Sweden Gerdtham and Sundberg (1998)
Malaysia Yu et al. (2008)
Switzerland Bilger (2008)
Palestine Abu-Zaineh et al. (2008)
Ireland Smith (2010)
Tanzania Mtei et al. (2012)
Iran Alireza (2011)
Ghana Akazili et al. (2011)
13 OECD countries Wagstaff et al. (1999)
10 OECD countries Wagstaff and Van Doorslaer (1992)
13 Asian countries O’Donnell et al. (2008a)
Smith (2010), Klavus (1998), Akazili et al. (2011), and Abu-Zaineh et al. (2008) analyzed the
inequity in financing through the Kakwani index as well as through a “disaggregated approach”;
the latter provides summary measures over specific income groups, by using the dominance test
to assess the level of progressivity for different deciles of income distribution.
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Another different method consists of separating the redistributive effect into three parts:
vertical, horizontal, and reranking effect. The works by Lairson et al. (1995) for Australia and
Gerdtham and Sundberg (1998) for Sweden concentrate on this approach. Bilger (2008) adopted
the same methodology in the case of Switzerland.
Many studies have analyzed the equity of health system financing at the national level, while
very few studies have explored this issue at the subnational level. Abu-Zaineh et al. (2008) and
Alireza (2011) extended the analysis by computing the Kakwani index for two different regions
of a given country: the former included in the study the two regions of the Occupied Palestinian
territory (i.e. the West Bank and the Gaza Strip) and the latter applied the Kakwani index to
urban and rural areas of Iran. As far as Switzerland is concerned, the issue of the health-care
system financing has been explored by Wagstaff and Van Doorslaer (1992); Wagstaff et al. (1999)
and Bilger (2008). All three papers provide evidence in favor of highly regressive financing.
Wagstaff and Van Doorslaer (1992) presented an international comparison of health-care
financing across 10 countries. The score of the Kakwani index for Switzerland was based on 1982
data and was significantly negative (-0.117). Moreover, the Swiss healthcare financing was the
second most regressive, after the U.S. (Kakwani index of -0.145).
In 1999, the same authors, along with some others, updated their previous paper with more
recent data. In line with their previous work, the analysis for Switzerland shows that the new
Kakwani index, based on the data of 1992, is -0.1402. In ten years the inequity level of financing
grew even worse.
Bilger (2008) provided another important contribution to the analysis of financing equity
in Switzerland. For his analysis, he used the Swiss Household Income and Expenditure Survey
(SHIES) of 1998, which contains data from 9295 Swiss households. He found evidence that
health system financing in post-reform Switzerland remains very regressive. In particular, the
paper concludes that the reform failed to reduce vertical inequity.
Starting from this strand of literature, the current paper aims to go a step further. The goal
is to analyze the differences in the regressivity of the financing system at a sub-national level.
Apart from the two previously noted exceptions (focusing on two regions of the same country),
this is the first attempt to provide a systematic analysis of financing equity at the level of the
single entities of a federal state (in this case, Switzerland at the cantonal level). Switzerland is
an ideal country in which to add this new piece of evidence, as it can be set in a context of fiscal
federalism, where the cantons have large freedom to decide on the financing sources for health
care and in the design of the tax system (Kriesi et al., 2005).
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1.3 Swiss health system financing
1.3.1 General framework
The Swiss health care system is based on a mixed private-social health insurance, and it is
financed through several sources (in brackets the 2009 shares on the total health care costs):
public expenditure (28%), mandatory health insurance (29%), general social insurances (6%),
complementary health insurance (9%), co-payments and out-of-pocket (27%), other private (1%)
expenses.
Public expenditure
Federal, cantonal and local authorities contribute to the health care system mainly in two forms:
• Direct subsidy of specific services (inpatient hospital care, nursing homes, home care),
mostly paid by cantons, and payment of public health interventions (like prevention and
health promotion).
• Indirect financing through earmarked subsidies for lower-income people who cannot afford
mandatory health insurance, funded jointly by the Confederation and the cantons, and
other means-tested allowances for specific target groups.
All these activities are financed through tax revenues: they include both direct and indirect
taxes for the Confederation, mostly direct taxes for cantons and municipalities. In particular
direct taxes consist of income taxes for the Confederation and both income and property taxes
for cantons and municipalities.
Mandatory health insurance (MHI)
The health insurance in Switzerland, mandatory since the reform of 1996, consists of a monthly
community rated premium that does not depend on the level of income. However, different
premiums are set for two age-classes: lower premiums for children (age <19) and higher for
adults. Moreover, insurers are free to grant a discount for students between 19 and 25. Health
insurance is offered through a variable number of private nonprofit sickness funds (ranging from
118 in 1998, to 85 in 2005 and to the current number of 66 in 2012). It covers a comprehensive
benefit basket fixed at the federal level. Coverage starts once the yearly deductible (minimum
of 300 CHF, about 330 US$, in the standard contract) has been reached and includes a 10
percent copayment (up to a maximum amount of 700 CHF per year). People can opt for higher
deductibles (up to 2500 CHF) and get in exchange a premium discount. Premiums are set at
the regional level by each health insurer. Some cantons are considered as a single premium
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community, whereas others (including urban and rural areas) are divided in two or three regions
(the total number of premium communities declined between 1998 and 2005 from 78 to 43).
As a consequence, premiums significantly differ across regions and cantons, reflecting the huge
differences in health care expenditures. Significant variation exists also across health insurers
(Ortiz, 2011), due in particular to a still ineffective risk adjustment mechanism (Beck et al.,
2010). Horizontal equity across geographic communities is not guaranteed at all, since individuals
with the same income pay significantly more or less depending on what premium region they
are resident in. Moreover, not even horizontal equity within the same premium region can be
completely achieved, due to competition in insurance market, switching decisions by consumers,
different deductibles and the option to sign managed care contracts.
As mentioned before, for people earning an income under a certain threshold, the Confedera-
tion and the cantons jointly fund earmarked subsidies that cover part or the total of the monthly
premium (full coverage concerns in particular retired and disabled people receiving means-tested
benefits).
General social insurances
This is Bismarckian insurance system designed to cover through in cash benefits other (non-
health) risks like longevity, disability and accident. In some circumstances it provides also
benefits through in kind health care services. It covers, in particular, spending for rehabilitation
in case of disability and the health care costs in case of professional and non-professional accidents
of employed persons.
Complementary health insurance
People can choose to pay a risk-rated premium (for individual contracts) or a community-rated
premium (for collective contracts) to have a voluntary supplementary private health insurance.
It covers some health-care services or inpatient hospital amenities that are not included in the
compulsory benefit basket.
Out-of-pocket
The out-of-pocket expenses include the co-participation to costs (namely the deductible and the
10% co-payment) as well as all other health care expenses not covered in the general contract
(e.g. nursing homes fees, dental care, OTC drugs, etc.).
Some of the financing strategy rules are decided at the federal level. However, Swiss federalism
allows cantons to make their own decision regarding the exact design of the financing policy they
want to adopt.
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The cantonal scope of action can take several forms. Firstly, a different mixture of the
financing sources chosen by each canton1 determines a different level of regressivity: cantons
that rely more on the MHI than on public expenditure are more likely to be regressive than
those that choose to finance the system more through general taxation. Secondly, cantonal
autonomy due to fiscal federalism allows significant leeway in deciding the subsidies policy for
the worse-off (Balthasar et al., 2008; Gilardi and Füglister, 2008; Kägi et al., 2012). Cantons are
allowed to make their own decisions regarding the eligibility criteria for receiving benefits, which
creates heterogeneity in their distribution and which leads to differences in the level of regressivity
among cantons. Thirdly, each canton has significant leeway in the definition of the tax rates for
income and property taxes, whereas each municipality decides every year the percentage of the
cantonal tax liability to be paid as local taxes.
According to cantons’ choices, different equity (or inequity) levels are thus determined.
1.3.2 Evidence of heterogeneity at the cantonal level
Due to data availability problem, in the analysis that follows we are forced to rely only on the
first three funding sources in the list, i.e. public financing, MHI and general social insurances.
The part of financing that we are considering is called socialized health expenditure (SHE), since
it reflects collective spending for the universally accessible basket of health care benefits. It
accounts for approximately 60-65% of the total financing in Switzerland.
Hence, in our analysis, we will decompose SHE in four sources: federal taxes (including direct
tax and VAT), cantonal and municipal taxes (henceforth we will refer to this second group of
tax simply as cantonal tax), mandatory health insurance (computed as net premium, i.e. the
difference between the privately paid premium and the earmarked subsidies), and general social
insurances2.
The first column in Table 1.2 considers the amount of the SHE for each canton and for
Switzerland as a whole in absolute per capita values for 2005. The second column shows the
incidence of SHE on average disposable income.
The last four columns of Table 1.2 represent the proportion of the expenditure financed by
each source. We computed these weights as an average for the considered period (1998-2005).
The first evidence from the table relates to the absolute level of expenditure which differs
1E.g. until 2011 cantons had significant leeway in allocating the public financing to private hospitals. This
has been changed by the new regulation of hospital financing that started in 2012.
2The available data does not provide any information about the direct federal health expenditure given to each
canton or the amount of health expenditure from the general social insurance spent in each canton. To compute
these two values, we took the total amount of expenditure and simply imputed the same average spending for
each Swiss inhabitant, regardless of the canton in which she/he lives. In the expenditure of the confederation and
the cantons, we also accounted for the amount of the subsidies distributed.
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Table 1.2: Socialized health expenditure – Absolute value (2005) and share of each financing
source (average 1998-2005)
SHE per
capita
(CHF)
SHE as a
share of
average
disposable
income
Sources of financing
Federal
taxes
Cantonal
and
municipal
taxes
General
social
insurances
Mandatory
health
insurance
(net
premiums)
Zurich (ZH) 4198 6.66% 10.00% 29.00% 13.00% 48.00%
Bern (BE) 4297 8.52% 11.00% 30.00% 13.00% 46.00%
Lucerne (LU) 3461 7.19% 13.00% 25.00% 16.00% 46.00%
Uri (UR) 3379 6.85% 13.00% 26.00% 16.00% 45.00%
Schwyz (SZ) 3581 6.14% 13.00% 25.00% 15.00% 47.00%
Obwald (OW) 3155 7.40% 14.00% 27.00% 16.00% 43.00%
Nidwald (NW) 3385 6.21% 13.00% 27.00% 16.00% 44.00%
Glarus (GL) 3541 8.01% 12.00% 30.00% 14.00% 44.00%
Zug (ZG) 3885 5.15% 12.00% 30.00% 14.00% 44.00%
Fribourg (FR) 3876 8.42% 12.00% 28.00% 14.00% 46.00%
Solothurn (SO) 4002 7.78% 11.00% 26.00% 14.00% 49.00%
Basel City (BS) 5854 9.31% 8.00% 39.00% 9.00% 44.00%
Basel Land (BL) 4197 7.60% 11.00% 27.00% 13.00% 49.00%
Schaffausen (SH) 4070 9.06% 11.00% 31.00% 13.00% 45.00%
Appenzell O. Rhodes (AR) 3505 6.33% 13.00% 27.00% 16.00% 44.00%
Appenzell I. Rhodes (AI) 2988 6.81% 16.00% 20.00% 19.00% 45.00%
St. Gall (SG) 3465 6.76% 13.00% 24.00% 15.00% 48.00%
Grisons (GR) 3837 7.18% 12.00% 29.00% 14.00% 45.00%
Argovia (AG) 3575 6.60% 13.00% 20.00% 15.00% 52.00%
Thurgovia (TG) 3204 7.10% 14.00% 19.00% 16.00% 51.00%
Ticino (TI) 4852 9.66% 10.00% 29.00% 12.00% 49.00%
Vaud (VD) 4858 9.01% 9.00% 30.00% 11.00% 50.00%
Valais (VS) 3732 8.32% 12.00% 30.00% 14.00% 44.00%
Neuchâtel (NE) 5017 10.44% 9.00% 33.00% 11.00% 47.00%
Geneva (GE) 6578 10.10% 7.00% 43.00% 8.00% 42.00%
Jura (JU) 4381 10.43% 10.00% 30.00% 12.00% 48.00%
Switzerland (CH) 4243 7.85% 11.00% 29.00% 13.00% 47.00%
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greatly across cantons. With respect to the Swiss average of 4243 CHF (registered in 2005,
the latest year considered in the empirical analysis), canton Geneva and Basel City present the
highest value of expenditures, with 6578 and 5854 CHF, respectively. Cantons Appenzell Inner
Rhodes and Obwald register the smallest expenditure values (with 2988 CHF and 3155 CHF,
respectively). As far as the incidence is concerned, it ranges from 5.15% of disposable income
in the rich and low SHE canton of Zug to almost the double in Geneva, Jura and Neuchâtel.
Whereas in Geneva it is the high level of SHE that determines the heavy burden for households,
in Jura (where SHE is aligned with Swiss average) the high incidence is rather driven by a low
average income.
However, the differences do not only concern the total amount of expenditure: another evident
difference between cantons is the proportion of each of the single financing sources.
The table also shows that, in cantons where the total expenditure is higher, the share of the
cantonal part tends to be also higher. This is because, where health care costs (and consequently
premiums) are higher, many households cannot afford anymore the cost of mandatory health
insurance, which means that cantons are forced to spend more in terms of subsidies for the
worse-off.
The values in the table show that the most important part is financed by health insurers. This
accounts, on average, for 47 percent of the SHE. The second source derives from the cantonal
taxes that cover 29 percent of the SHE, followed by the social insurances and federal taxes that
account for 13 percent and 11 percent, respectively.
Finally, it is worth noting the magnitude of the differences among cantons. There are two
cantons for which the part financed by cantonal taxes is considerably larger (Geneva - 43 percent;
Basel City - 39 percent), whereas in Appenzell Inner Rhodes the share financed by cantonal taxes
corresponds to only 20 percent.
1.4 Dataset
The micro dataset is the Swiss Household Income and Expenditure Survey (SHIES), which allows
computation of household income at a very detailed level, including all the taxes and social
contributions paid, as well as the health expenditures (premiums and, only to some extent,
out-of-pocket expenditures) and indemnities related to health (subsidies from the state and
reimbursements from the insurance companies).
This survey is available from 1998 to 2005 (excluding 1999) and is based on a sample of the
Swiss population (approximately 3500 households observed for each of the years between 2000
and 2005, and 9295 observations for 1998).
The SHIES does not guarantee that the households sample is representative at the level of all
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cantons for each year, but only at the level of seven macro-regions, each of which groups cantons
together according to their geographical position3. As the focus of this work is to control for the
differences due to the federal setting, we were interested in maintaining the cantonal dimension.
For this reason, we decided to merge the dataset of each year to obtain a representative sample
at the cantonal level. This has been possible because different people were interviewed each year
for each canton. In this way we were able to control for the cantonal differences, but we lost the
information about the variation over time for each canton.
Ultimately, this study concentrates on the between-variation for each canton and on the
within-variation only for the whole Switzerland and the seven macro-regions. There are some
differences in the questionnaires, especially for the year 1998 with respect to the other years. Only
in the wave of interviews taken in 1998, were people asked to report all the medical expenses
(greater than 150 CHF) they had during the whole year preceding the month of the survey
and not only all the medical expenses they had during the month of the interview (as it is in
the other waves of the survey). Moreover, only for the year 1998 responders had to register
the reimbursements received by the insurance companies during the whole year; hence there
was a correspondence between the expenditures and their reimbursements. The collection of
this data makes it possible to compute the out-of-pocket expenditures for each households and,
consequently, to have a robust proxy for the yearly out-of-pocket financing at least for the year
1998.
1.5 Methods: Kakwani index, concentration curves and domi-
nance test
In order to measure the regressivity of each financing source, we used the procedure proposed
by Wagstaff et al. (1999), (see also O’Donnell et al. (2008b) for the empirical implementation).
We started by computing the Kakwani index for each financing source and then we computed
a total Kakwani index aggregating these results with a weighted average, using as weights the
proportion of each financing source with respect to the total financing. This procedure has been
applied to 23 cantons4, to the seven macro-regions, and to Switzerland as a whole.
This index is computed as the difference between the concentration index of each financing
3Macro-region 1 includes Vaud, Valais, and Geneva; macro-region 2 includes Bern, Fribourg, Solothurn,
Neuchâtel, and Jura; macro-region 3 includes Basel City, Basel Land, and Argovia; macro-region 4 includes
Zurich; macro-region 5 includes Glarus, Schaffhausen, Appenzell O. Rh., Appenzell I.. Rh., St. Gall, Grisons,
and Thurgovia; macro-region 6 includes Lucerne, Uri, Schwyz, Nidwald, Obwald, and Zug; macro-region 7 includes
Ticino.
4Canton Uri, canton Appenzell I. Rhodes, and canton Appenzell O. Rhodes have not been considered because
the small number of observations in the dataset did not allow for any robust computation.
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source and the Gini index calculated on the (equivalent disposable) household income before
considering any health-related expenditures (we refer to this as pre-health income). If the two
curves coincide, the difference between the CI and the Gini index is zero and the financing source
can be considered as proportional to income.
The formula is as follows:
Kip = CIip −Gini_prei Range : [−2 : +1] (1.1)
where i indicates the geographical unit of analysis and p the different financing sources
available in the dataset.
CIip is the concentration index of each financing source p. CI is twice the area between the
concentration curve of the source p and the 45-degree line. It indicates whether the variable of
interest is more concentrated among the poor (the concentration curve lies above the equality
line and the index has a negative value) or among the rich (the curve lies below the equality line
and the index has a positive value).
Gini_prei is the Gini index for the pre-health income.
Since the Swiss fiscal system does not rely on earmarked taxes for health care, we simply
imputed to the amount of taxes paid by each household the share of total health expenditure
financed by that tax. We did this for federal tax, cantonal tax, and also for general social
insurances.
Gini_prei is computed according to the following formula:
y_preh =
N∑
k=1
yhk −
m∑
s=1
(1− µs)schs −
p∑
v=1
(1− τv)thv (1.2)
where:
• ∑Nk=1 yhk is the gross income for the household h, which, according to the definition given
in Bilger (2008), consists of the sum of all income earned from work and self-employment,
interest, house rental, social insurance benefits, revenues from other insurances, and other
indemnities.
• ∑ms=1(1− µs)schs is the part of the general social insurance paid by the household h and
not directed towards financing health care. In particular, µs is the share of health care
services funded out of the budget of the social insurances. In 2005, µs was 3.3 percent for
the pension and the disability insurance, and 24.5 percent for the accident insurance.
• ∑pv=1(1 − τv)thv are the taxes (federal, cantonal and municipal) paid by the household
h and not directed towards financing the healthcare system. As in Bilger (2008), federal
indirect taxes were proxied with VAT, which accounts for two-thirds of total indirect taxes.
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VAT has been computed from the data on consumptions that household declared in the
survey.
As in the case of social contribution, τv is the part used to finance the health care system for
each type of tax (v), so 1− τv is the residual part that is not used within the health sector.
To give an idea of the dimension of these coefficients, in 2005 τv was 5.4 percent for federal
tax, 28.5 percent (on average) for cantonal tax and 4.3 percent (on average) for communal tax.
Disposable income before health-care financing has been corrected using an equivalence scale
in order to make households with a different number of members comparable5.
Moreover, as different years are pooled together, the values have been deflated through the
consumer price index (CPI) for Switzerland.
Kakwani is a useful index for providing information about the shift from proportionality.
However, it is an extremely summary measure, and its information can be sometimes misleading
if the distributions underlying the Kakwani index are not considered alike. When curves cross, a
value of Kakwani equal to zero could be the result of a concentration curve that is progressive for
half of the population and regressive for the other half. To control for this, we look also at the
concentration curves and the relative dominance test, that aims to define statistically whether
one curve dominates another. The null hypothesis indicates that there is no significant difference
between the two concentration curves considered. The choice criterion used here is the multiple
comparison approach. In the comparison between the two curves, the null is rejected if there is at
least one significant difference between them in one direction and no significant difference in the
other direction. The ordinates are compared in 19 different quintiles, as suggested by O’Donnell
et al. (2008b)
1.6 Results
Table 1.3 presents the results of the Kakwani index over time for the whole Switzerland and for
the seven macro-regions.
The most notable result is that the total value of the Kakwani index is always negative, which
means that the Swiss health-care system financing remains regressive, even after the major reform
of 1996; this result is in line with the previous literature. The other notable point is that the
results do not seem to vary widely in the years considered, neither for all of Switzerland nor
for any of the macro-regions. The most regressive year appears to be 1998, although the data
provides no evidence of any clear temporal trend.
5The scale chosen is the OECD modified equivalence scale, which assigns a value of 1 to the household head,
of 0.5 to each additional adult member and of 0.3 to each child no older than 13.
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Table 1.3: Kakwani index over time
1998 2000 2001 2002 2003 2004 2005
Macro-region 1 -0.136** -0.091** -0.069** -0.065** -0.099** -0.090** -0.074**
[1495] [590] [586] [603] [528] [505] [502]
Macro-region 2 -0.106** -0.081** -0.081** -0.109** -0.105** -0.085** -0.109**
[2173] [925] [907] [840] [788] [780] [751]
Macro-region 3 -0.103** -0.099** -0.044* -0.062** -0.065** -0.076** -0.084**
[1287] [504] [516] [529] [482] [441] [400]
Macro-region 4 -0.130** -0.138** -0.092** -0.094** -0.104** -0.111** -0.112**
[1659] [638] [612] [640] [622] [562] [531]
Macro-region 5 -0.130** -0.116** -0.125** -0.119** -0.084** -0.137** -0.147**
[1183] [433] [478] [469] [438] [420] [417]
Macro-region 6 -0.136** -0.135** -0.080* -0.089** -0.108** -0.125** -0.075**
[806] [329] [300] [313] [289] [287] [245]
Macro-region 7 -0.087** -0.074** -0.078** -0.034 -0.027** -0.083** -0.016**
[692] [223] [341] [332] [328] [275] [241]
CH -0.130** -0.110** -0.084** -0.094** -0.098** -0.104** -0.101*
[9295] [3642] [3740] [3726] [3475] [3270] [3087]
Significance level: *p < 0.05, **p < 0.01.
The values in brackets show the sample size.
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Macro-region 7 (Ticino) seems to reach the best value in terms of equity, for all the years
considered, since the Kakwani is not statistically different from zero in 2002, 2003 and 2005.
Macro-region 4 (Zurich) is in line with the Swiss average, and macro-region 3 (Basel City, Basel
Land, and Argovia) is, after Ticino, the least regressive group of cantons.
The weighted Kakwani index for the SHE in Switzerland ranged from -0.084, reached in 2001,
and -0.13 in 1998.6
Table 1.4 presents the Kakwani indexes for the Swiss cantons and helps shed light on how
fiscal federalism allows cantons to choose their preferred financing policy.
It is evident from the table that there are important differences in the regressivity of the
financing system among cantons.
The Kakwani index for federal taxes is not statistically different from zero for all the cantons
apart from canton Basel Land (BL), which has a slightly progressive value. This means that
federal taxes are concentrated quite proportionally among the population. This result could be
easily explained if we think that the tax amount considered here is the sum of a progressive
federal direct tax (based on income) and an indirect tax (VAT) based on consumption that is
normally regressive. Canton Basel Land is the only one in which the effect of the progressive
direct tax more than offsets the effect of the regressive VAT.
The Kakwani indexes for the cantonal and municipal taxes are more difficult to explain.
While we would expect a highly progressive value, most of them are not statistically different
from zero. Only Solothurn (SO), Ticino (TI), and Basel Land (BL) present a slightly positive
value of the Kakwani index, which means a slightly progressive tax. These values are smaller
than the results expected, but there are at least two reasons that could explain them.
First of all, this financing source includes both cantonal and municipal tax. Very rich house-
holds may choose to live in jurisdictions that have a lower local (municipal) taxation. Therefore,
a richer household may have to pay the same cantonal tax, but a different (lower) municipal tax
than a poorer household that lives in a municipality with higher taxation. This could bias the
progressivity results in favor of a score that cannot reject the hypothesis of proportionality.
A second reason could be the fact that there is a mismatching between household income
that refers to the year of the interview and household taxes that are paid on income earned the
year prior to the interview. There could be situations in which a person has reduced his or her
revenues (perhaps because they have temporarily lost their job or have retired), but reports to
pay high taxes because she/he earned a “regular” income in the previous year. This could worsen
the situation of regressivity because the Kakwani index is computed as if tax paid and income
6As explained in section 4, data for 1998 was collected in a different manner that makes it possible to compute
the Kakwani index for the total health expenditure, including the out-of-pocket payment and the complementary
insurance. We computed this for all of Switzerland and found that the equity results are even worse (Kakwani
-0.14).
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Table 1.4: Kakwani index across cantons
Number
of obser-
vations
Federal
Taxes
Cantonal
and mu-
nicipal
taxes
General
social in-
surances
Mandatory
health insurance
(net premiums)
Weighted
Kakwani
index
ZH 5264 0.0088 0.0389 0.0074 -0.2548** -0.1085**
BE 4191 -0.0052 -0.0121 0.0330** -0.20806** -0.0947**
LU 1353 -0.0069 0.0181 0.0560** -0.2298** -0.0936**
SZ 450 -0.0578 -0.0417 0.0025 -0.2508** -0.1344**
OW 129 0.0387 0.0744 0.0999** -0.2323** -0.0567**
NW 158 0.0236 0.1256 0.0594 -0.2738** -0.0729**
GL 138 0.0063 0.0135 0.0366 -0.2304** -0.0913**
ZG 375 0.1093 0.0540 -0.0230 -0.2603** -0.0871**
FR 916 -0.0159 -0.0121 0.0246 -0.1863** -0.0874**
SO 1013 -0.0311 0.0473** 0.0536** -0.2109** -0.0868**
BS 782 0.0485 0.0835 -0.0001 -0.2149** -0.0582**
BL 1066 0.0557* 0.0933** -0.0042 -0.2191** -0.0774**
SH 295 -0.0963 -0.1310 -0.0059 -0.2239** -0.1535**
SG 1648 0.0011 0.0407 0.0369* -0.2571** -0.1066**
GR 723 -0.0481 -0.0327 0.0231 -0.2605** -0.1285**
AG 2311 0.0200 0.0308 0.0147 -0.2250** -0.1065**
TG 806 0.0251 -0.0372 0.0406* -0.2281** -0.1131**
TI 2432 0.0122 0.0850** 0.0310* -0.1800** -0.0592**
VD 2531 -0.0148 0.0131 -0.0099 -0.2050** -0.1004**
VS 1083 -0.0464 -0.0435 -0.0006 -0.2123** -0.1114**
NE 776 -0.0526 0.0306 -0.0035 -0.2009** -0.0904**
GE 1195 0.0277 0.0976 -0.0673** -0.2482** -0.0643*
JU 268 -0.0076 0.0799 0.0549 -0.1809** -0.0566**
CH 30232 0.0074 0.0153 0.0090* -0.2271** -0.0999**
Significance level: *p < 0.05, **p < 0.01.
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earned referred always to the same year7.
As expected, the Kakwani indexes for the general social insurance are not statistically dif-
ferent from zero. Since the tax rate is the same for every wage earned, regardless of its level, we
expected a Kakwani value near to zero. Nevertheless, there are some exceptions. Four cantons
(Bern, Lucerne, Obwald, and Solothurn) present a progressive value, while canton Geneva is the
only one that has a regressive index for this financing source. This could be because the share
of capital income over the total income in Geneva is higher than in the other cantons (and,
consequently the wage income share is lower): the fact that the payment for the social insurance
is only based on wage income could induce a regressive effect in the results.
The most interesting results are those for the mandatory health insurance. They are all
significant for each canton and range from a value of -0.18 for canton Ticino to -0.27 for canton
Nidwald.
It is quite notable that the values can be so different, even in neighboring cantons: the value
of the index in canton Grisons (-0.26) is 0.08 less than that of its neighbor, Ticino (-0.18). Based
on the Welch’s t-test, we can show that this difference is statistically significant at the 95% level.
This outcome probably hides a different choice in the subsidy policy that cantonal authorities
are free to set-up. Previous studies (see Balthasar et al. (2008); Ortiz (2011)) have shown that
on average the same family (e.g. parents with two children and a revenue of 70’000 CHF) has
to devote 4.4% of disposable income if it lives in Obwald, but up to 16.4% if the canton of
residence is Vaud. This heterogeneity jointly reflects the premium level and the generosity of
the subsidy policy. In general cantons with a very high level of premiums prefer to distribute
generous subsidies to a limited group of citizens, whereas those with lower premiums levels choose
to reach more people by distributing lower subsidy amounts (OECD/WHO, 2011). There is one
clear outlier-canton which distributes higher subsidies than the average to an above-average share
of the population, namely Ticino (Crivelli et al. (2007) show that the subsidy policy in Ticino
is 34.5 percent more generous in terms of CHF spent per capita than the Swiss average). This
might explain why in Ticino the net premiums are less regressive than elsewhere. On the other
hand Grisons distributes subsidies that are below the Swiss average and support only a limited
number of people. This strategy seems to be in line with the computed Kakwani for MHI, which
is in the case of Grisons the most regressive one.
Finally, the results on the total Kakwani indices are all statistically significant8 and all
7There is another factor to consider: the tax reform. From 1990 until 2003 cantons, in turn, had to adapt their
system of taxation to a new one. This passage provoked an asymmetry between the tax paid in one year and the
income earned in the same year that may have brought some additional asymmetries also in our computations.
8The standard error for the total Kakwani index have been obtained summing the standard errors for the
single components (i) according to the formula:
se =
√∑
i(wise
2
i ) + 2
∑
ik(wiwjcovij) ∀i 6= j
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negative.
The cantons that appear to be the most regressive ones are canton Schaffhausen and Schwyz,
with a Kakwani equal to -0.15 and -0.13, respectively. The cantons that reach the best results
in terms of equity are Jura, Obwald and Ticino, all of which have a Kakwani value of around
-0.05.
It is worth noting that the difference between the least (Jura) and the most regressive canton
(Schaffhausen) is considerable (approximately 0.10) and significant at 99% level (according to
the Welch’s t-test); it is the same as the difference between the US (-0.13) and Sweden (-0.015)
from the Wagstaff et al.’s (1999) study, countries that have two completely different health-care
financing systems. Although Shaffausen and the Jura have greater absolute levels of regressivity
than the US and Sweden respectively.
We now report the concentration curves and the dominance tests results.
Figure 1.1: Concentration curves for each financing source, canton Geneva.
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A general summary comment, based only on the visual inspection of the concentration curves,
would suggest that their order follows a similar pattern for all the cantons. Firstly, starting from
the 45-degree line and going down, the net premium curve is always the first one, very close to
the 45-degree line and not crossing with the others. Secondly, the social contribution curve is
generally the next one, always very near to the Lorenz curve, which indicates proportionality.
Thirdly, the federal tax line is also quite near to the Lorenz curve and, finally, the cantonal tax
curve is always the most distant and lies under the Lorenz, indicating progressivity. Nevertheless,
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the two curves for taxes and the one relative to the social insurance often cross among them and
with the Lorenz, which indicates an alternation between regressivity among the poorer and
progressivity among the richer.
We have chosen to show the results only for canton Geneva, which is among the least regres-
sive.
Figure 1.1 represents the concentration curves of each financing source. The concentration
curve for the net premium is very close to the 45-degree line, indicating quite strong regressivity,
and it dominates the Lorenz curve. In Table 1.5 we read that the poorest 30 percent of the
population receives about the 15 percent of the total income and pays 26 percent of the net
premium.
Table 1.5: Cumulative shares of income and health payments by income decile, canton Geneva
Quantile Cum.
share of
income
Cum. share of
federal taxes
Cum. share
of cantonal
and municipal
taxes
Cum. share
of general so-
cial insurances
Cum. share
of mandatory
health insurance
(net premiums)
Q10 2.78% 6.26%** 4.32% 4.57% 8.08%**
Q20 8.24% 10.55%* 7.40% 10.06% 16.62%**
Q30 14.75% 15.61% 11.21%* 16.87% 26.16%**
Q40 22.35% 22.04% 16.60%** 23.15% 36.71%**
Q50 30.82% 29.29% 23.69%** 31.75% 47.10%**
Q60 40.31% 37.41% 32.80%** 43.70%* 57.73%**
Q70 50.92% 46.08%* 42.95%** 55.78%** 68.60%**
Q80 62.85% 57.53%* 53.94%** 70.27%** 79.40%**
Q90 76.98% 71.94% 69.61%* 83.72%** 89.47%**
Significance level: *p < 0.05, **p < 0.01. The significance level indicates whether the percentage share of
financing source is significantly different from the income_pre.
The tests of dominance (not shown in the table) find evidence of dominance of the social
contributions curve on the Lorenz curve and dominance of the Lorenz curve on the cantonal
tax curve. These two last results tell us two important things. Firstly, the dominance for the
social contribution curve confirms the result of the Kakwani index: the social contributions are
regressive in Geneva, while the situation is different for the cantonal tax. This financing source
seems to be progressive, but only starting from the second decile of the ranked population (i.e.,
for the richest 80 percent). For the poorest 20 percent of the ranked population, we cannot reject
the hypothesis of proportionality (as the difference between the two curves is not statistically
significant).
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1.7 Discussion: lessons for a federal state
The most relevant evidence is that the regressivity of the MHI implies that the subsidy policy
adopted by the state does not succeed in making the financing of this source progressive or, at
least, proportional. Considering that the subsidy is the most important tool that cantons have
to mitigate the regressive nature of the community-rated premiums, this is a very strong result
for policy makers.
However, the value of Kakwani here includes something more than the effects of the earmarked
subsidies chosen by the cantons. Also, the individual choices (premium and deductible) allowed
by the competitive setting of the Swiss health insurance have a significant impact on equity.
The Swiss system encourages competition between insurance companies, which plays out in
the level of the premium and in the quality of service; twice per year, people have the option to
switch to another insurance company (with lower premiums, e.g.). Moreover, citizens are allowed
to obtain a discount on the monthly premiums by choosing a higher deductible; by assuming
some of the financial consequences of getting sick themselves, they can pay a smaller monthly
premium9. Finally, people who choose to be part of a managed care plan can also get a discount
on premiums. These choice options are not constrained to a certain level of income, but there is
evidence that not all citizens can manage the available information to make a rational choice in
terms of switching (Ortiz, 2011) or of selecting the appropriate type of contracts. Accordingly,
we cannot exclude the existence of a social gradient in the ability to manage information. In
this case, the burden of solidarity with the sick implied by community rating may be partially
shifted back from the good risk to the bad risk as well as from the better off to the worse off,
with negative consequences on the equity level.
Similarly, the Kakwani index of taxation includes also an indirect (or endogenous) effect
due to individual choices. For example, very rich people may decide to live in a canton (or
municipality) with a less progressive taxation to pay less taxes and this may also have an impact
on the regressivity level of the canton. If this effect increases or decreases the regressivity depends
on the distribution of income among the population.
Another consideration needs to be specified. The Kakwani index considers only the relative
financing burden of households with respect to others, not the absolute burden of the health
financing. The poor in a canton with a slightly regressive financing may have to pay absolutely
more for health care than people with the same income in a canton with highly regressive
financing.
In other words, the Kakwani index is appropriate to measure the level of vertical inequity,
9Financially constrained households may ‘underinsure’ by choosing higher deductibles or switching to a more
restrictive insurance plan (managed care). Hence they may incur higher out of pocket payments, which are not
measured in the study and which would underestimate the inequity level.
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but it is not able to capture the extent of horizontal inequity.
To have an idea of the dimension of horizontal inequity, we computed the incidence of health
expenditure on the total income for different income classes. We found that there is a similar
general trend for all cantons; specifically, the incidence for the lower-income classes is heavy and
decreases for the richer classes.
To exemplify this, the graphic representations for the incidence of the financing burden for
the cantons of Zug and Geneva are reported below (Figure 1.2).
Figure 1.2: Average incidence of the socialized health expenditure on income, Zug (left) and
Geneva (right).
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The red line represents the average incidence for each of the income classes considered, while
the blue-shadow area indicates the confidence intervals. Interestingly, the two red lines have a
similar shape, although the line for Geneva is shifted upwards with respect to the other.
With an exception for the first income class, the level of incidence is quite different: the share
of income that people in Geneva pay is almost double that of citizens earning an equivalent income
in Zug. This means that people in Geneva (one of the least inequitable cantons) pay more, not
only in absolute value, but also as a percentage on their income than in Zug (one of the most
inequitable cantons in terms of the Kakwani analysis).
The reason for such a result can easily be found by simply looking again at the absolute level
of expenditure (Table 1.2): Geneva registers one of the highest levels (6578 CHF per capita),
while Zug has one of the lowest ones (3885 CHF per capita).
This example clearly shows that the burden of health-care financing may be equally dis-
tributed, but may be too heavy to be affordable for lower- and middle-income people. To have a
clear understanding of the equity issue, the importance of the absolute expenditure levels cannot
be neglected.
The fact that people of the same income class show a different incidence level across cantons
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suggests the presence of horizontal inequity. We would like to highlight a final remark upon this
issue. The Swiss federalism allows some form of autonomy to cantons, especially in deciding
the subsidy policy. Therefore, subsidies are an important tool in reducing the vertical inequity
within a canton, but, on the other hand, being administered differently in each canton, they may
also lead to further horizontal inequity, i.e. to more inequity across cantons.
Finally, we cannot disregard that one possible criticism with respect to the equity issue is
the potential trade-off between equity and efficiency, according to what Okun theorized in 1975
(Okun, 1975). To check for this, we considered the efficiency results found in a study by Widmer
and Zweifel (2012) in which they performed a data envelopment analysis for the Swiss cantons
for six categories of public goods, including health, using data relative to the years 2000-2004.
We ranked the cantons first according to our equity results and then according to the efficiency
results found by the two authors. We compared the two ranking lists through a Spearman
test and a Kendall test of rank correlation, but the results do not reject the null hypothesis
of independence. This leads to the conclusion that there is no direct link between equity and
efficiency in this particular setting.
1.8 Conclusions
This study represents the first attempt to investigate the impact of federalism on the financing
of a universal health insurance system in terms of equity.
We have analyzed the financing of the Swiss health-care system from an equity point of view,
with particular attention to the differences across cantons. We used the Kakwani index for each
financing source to see how each of them shifts from proportionality. The dominance test for the
concentration curves has also been performed to exploit more the available information.
The general results suggest that Swiss health-care system financing is regressive in all cantons,
although there are huge differences among them. The reason for this lies in the federal setting,
which allows cantons to have some freedom in certain areas, such as how to design subsidy
policies for lower-income people, the choice of tax rates, and the choice of how much of the
total expenditure has to be financed through taxation and how much through mandatory health
insurance. These factors, along with the characteristics of the Swiss health-care system based
on competition among insurance companies and on the supply of premium discounts for people
opting for higher deductibles and managed care contracts, bring different levels of inequity. The
results highlight the fact that the level of regressivity of mandatory health insurance premiums
(net of subsidies) varies significantly across cantons, whereas for federal taxes and general social
insurance the hypothesis of proportionality cannot be rejected in the majority of cantons. Finally,
the cantonal tax is progressive only in three cantons.
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The main limitations of our paper are due to the dataset on which we relied; we had to
aggregate data of seven different years to get robust estimates at the cantonal level. Moreover,
we had to focus on SHE because the information on out-of-pocket expenditure was not reliable
for six out of seven years. Since 2008, a new legislation has been enforced in Switzerland that
assigns to cantonal authorities even more leeway regarding the subsidy policy (the matching
grants transfer has been replaced by a lump-sum payment). It is therefore necessary to monitor
the situation in more recent years in order to figure out how inequity developed in Swiss cantons
after this reform.
The results contained in this work shed light on some aspects that should be considered
in other federal states that are planning to use the regulation of private health insurance and
premium subsidies to ensure universal coverage. Although the combination of community rating
and premium subsidies might be in theory the best solution in terms of (vertical) equity (Kifmann
and Roeder, 2011), in the daily practice of federal states the empirical evidence can point to a
different outcome. In fact, tax competition and a “race to the bottom” in social policy (in order
to avoid the outflow of good taxpayers and the inflow of people looking for social aid) may jointly
lead to a lower level of vertical equity than a sovereign state would choose if the design of social
policy would occur at the national level.10
10In 1991, through the HIA draft bill, the Swiss federal government suggested to fix the maximum incidence
level for health insurance premiums at 8% of the taxable income. However, this ‘social target’ was not anchored
in the law and cantons were entrusted with large autonomy in the design of their subsidy scheme. In actuality, in
several cantons a large part of the population pays for premiums a share that significantly exceeds this threshold
(Balthasar et al., 2008; Ortiz, 2011).
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Chapter 2
Equity in the Swiss health care system:
the role of managed care and higher
deductible
Keywords
Equity, inequality, managed care, doctor visits.
2.1 Introduction
Switzerland, as many other OECD countries, has adopted an egalitarian view regarding the
organization and the delivery of health care services. This means that the health care system
is considered equitable in the utilization if people with the same health care needs are treated
equally, irrespective of their socio–economic conditions. In line with the literature that inves-
tigates this topic, we refer to the concept of horizontal inequity any time the differences in the
health care utilization are amenable to a different socio–economic condition. In this paper, we
focus on the equity in utilization taking into account the recent Swiss health care system changes.
Equity in access to health care has not emerged as a big issue in Switzerland in the past
years. Leu and Schellhorn (2004) analyze equity in access to health care in Switzerland over
time. Their analysis is based on data from the “Socio Medical Indicators for the Population of
Switzerland” for 1982 and on the “Swiss Health Survey” for the years 1992, 1997 and 2002. They
assess the level of horizontal equity for each year and report separate estimates for visits to the
general practitioner (GP) and to specialists. Results suggest that there is little or no inequity
in GP consultations, whereas specialist visits are pro rich distributed. The authors find little or
no variation over time.
Van Doorslaer et al. (2006) perform a similar analysis looking at inequality in the use
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of medical care in 21 OECD countries in 2000. They compute inequity in doctor utilization
through the concentration index of the need–standardized use. Results for Switzerland suggest
that specialist visits are slightly distributed in favor of rich people, while there is no evidence of
horizontal inequity for GP visits.
Allin et al. (2009) compare the socioeconomic inequality in the use of health care services
based on wealth and income, separately. The ultimate goal of the paper is to investigate the
sensitivity of the measures of equity to the different socioeconomic indicators. Data comes from
the Health and Retirement Study in the US and the Survey of Health Ageing, and Retirement
(SHARE) in Europe, for the year 2004. Regarding Switzerland, the authors find that the prob-
ability of visiting a doctor is slightly pro–rich distributed, but only conditional on income, not
on wealth. Nevertheless, the authors specify that results on Switzerland are not robust due to
the small sample size.
We can assume from these studies that the inequity in health care utilization in Switzerland
is not a source of big concern. Pro-rich inequity in the distribution of specialist visit is actually
an issue, but it is compensated by the slightly pro–poor distribution of GP visits. Compared to
the other European countries, on average Switzerland ranks in mid positions for the inequity in
doctor visits.
Nevertheless, there are no recent studies able to attest that inequity in health care utilization
has not become an issue after the recent evolutions of the health care system. The analysis
of the equity in the access to medical services for the years 2007 and 2012 is of particular
interest if considered in relation to the main challenges that the Swiss system has been facing in
these years. The surge in health care costs and the consequent increase in insurance premiums,
pushed a large share of population to adhere to new forms of contract that allow them to
benefit from a substantial discount on the monthly paid premiums of statutory health insurance.
These alternative forms of insurance are either contracts based on gatekeeping (such as managed
care contracts), or contracts with a higher deductible. Given that these contractual features
are generally adopted by healthier people (who are generally also the better–off), their larger
diffusion may have translated in a worsening of the inequity of the financing system (as already
discussed in chapter 1). On the other hand, we are not able to predict in advance their effect
on the inequity in access to care. If also individuals belonging to the first income quintiles have
enrolled in these plans, we cannot exclude that, on average, the inequity in the access to care
worsened. These contracts may have introduced some forms of barriers that somehow affected
the access to healthcare providers.
The goal of this paper is to explore the dimension of equality and equity in access to the
Swiss health care system in 2007 and 2012, trying to assess whether there is a trend that may
be traced back to the major changes of the Swiss health care system in the period considered.
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The analysis is focused both on federal level and on linguistic areas. Moreover, with respect
to the previous literature, we rely on a better empirical definition of needs. We use a large set
of variables to capture the need for health care, and to compute the need–standardized number
of visits.
Furthermore, it is worth highlighting that the time lapse in which our analysis is based
(2007–2012) includes the delicate years of the global financial crisis (2008–2009). Although in
Switzerland we do not find either evidence of significant cuts in the public sector due to the
crisis, or shortages of health care supplies, a report by the WHO lists Switzerland among the
countries that report a reduced use of health care due to financial barriers since 2008 (WHO,
2013). In a similar situation, it might occur that people who can rely on less economic resources
are those who choose to reduce the number of doctor visits, leading to an increased inequity of
health care system utilization. This leaves room for deeper research in this field.
In our analysis, we compute concentration indices for the distribution of visits to GPs and
visits to specialists for the years 2007 and 2012. We analyze the total number of visits, and
we also perform a two–step approach to separate the probability to consult a doctor from the
conditional number of visits. Our results suggest not only that specialist visits are pro-rich
distributed, in line with previous literature, but also that the pro–rich inequity worsened over
time. By contrast, no pro–rich inequity emerges in GP visits. If compared to the other European
countries, Switzerland’s inequity in access to care is one of the highest. It is close to the values
of countries such as Portugal or Italy, which rank in the second half of the list in terms of equity
in specialist visits (van Doorslaer et al., 2004).1
We also perform a decomposition analysis (on the probability of consulting a specialist)
to disentangle the contribution of the different sources of inequity. We show that some forms
of managed care contracts, and even more the choice for a higher deductible, are negatively
correlated with the probability of a specialist visit. However, since they are generally chosen by
richer and healthier people, their contribution ends up to be towards a more equitable distribution
of care. Being enrolled in a plan with higher deductible seems to reduce inequity in access to
specialist care. On the contrary, the analysis does not find any contribution to inequality due to
being enrolled in a managed care plan, neither in 2007, or 2012. We have to highlight that our
results are specific to the Swiss context, where the financing system assigns public subsidies to
the worse–off. Therefore, people who receive financial aid have no interest in saving money on
monthly premiums, and they generally opt for the basic insurance contract.
The paper is structured as follows. The next section will explain the major trends of the
Swiss health care system in the years 2007–2012. Section 2.3 illustrates the empirical methods
1Note that we are comparing results of different years. Results for Switzerland refer to 2007 and 2012, while
results for the other countries precede 2004.
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we use. Section 2.4 defines the dataset and the variables we employed in the analysis. Section 2.5
shows and discusses the results of the study. Finally, the last section concludes.
2.2 Recent trends in the Swiss health care system
After the reform of 1996 with the enactment of the Health Insurance Law, all Swiss residents
have to be covered by a statutory health insurance. Each insurer offers the same nationally
defined benefit basket, and competes on the level of premiums. Premiums may differ according
to the geographic area, three age categories (children, young adults between 18 and 25 and
adults) and insurance company. Premiums do not depend on income: a system of earmarked
subsidies, financed both by the Confederation and the cantons, provide financial aid for the
worse–off. Insurance plans may vary by deductible level; the higher the deductible, the higher is
the discount offered with respect to the basic premium. Furthermore, different forms of managed
care contracts are also available and allow for a discount on premiums in exchange for a reduced
freedom of choice2.
In the next subsections we discuss two recent trends: the increased popularity of managed
care plans and the further diffusion of higher deductibles.
Larger diffusion of managed care plans
Managed care contracts offer a discount on premium to the insured at the cost of a reduced
freedom of choice. Generally, in this form of insurance a certain physician (or group of physicians)
acts as gatekeeper: insurance holders need to have her referral for each (non–emergency) doctor
visit. Managed care plans encountered a large popularity in the US since 1980, while in Europe
they were completely unknown3. Switzerland was one of the first countries in Europe to allow
pilot projects with managed care in 1990, and to introduce this type of contracts in its legislation
in 1996, with the aim of containing health care expenditures. Nevertheless, this form of insurance
was not successful at the beginning and remained quite marginal for more than a decade. In
2004 the share of managed care contracts was still less than 10%, a rather low percentage if
compared to the US situation, where managed care contracts grew dramatically already in the
Eighties’; in 1993, 70% of all the insured had opted for a managed care plan (Glied, 2000).
In Switzerland, the managed care contracts may assume different forms (Beck et al., 2010).
First, the so–called health maintenance organizations (HMO), i.e. organizations that provide
(when physicians are independent) or arrange (if physicians are employed by the insurance)
2For a more detailed explanation of the Swiss health care system, refer to OECD/WHO (2011)
3We refer in this case to the European Bismarkian system, such as Switzerland, the Netherlands, Germany,
France, Belgium. In fact, the NHS (in Italy or UK) may generally be considered as a sort of public managed care.
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managed care for health insurances. Second, the general practitioner or family doctor model.
Third, the preferred provider list, where the choice of the doctor is limited to a list of names
chosen by the insurance. Also the call centers (known as “callmed option”) can be considered
a sort of managed care plan: a medical operator answers patients’ questions and refers them
to a physician, according to their need. Finally, the “insurance with bonus” is a contract that
provides a discount on premium only if the individual has not sought care during the last year.
Different from the other managed care plans, HMOs are “models with capitation”, meaning
that the network is collectively responsible for a financial budget, and that the provider–network
is remunerated by capitation for every individual enrolled in the plan. This financial responsibil-
ity is a strong incentive for the physicians not to prescribe unnecessary care. While some forms
of family doctor plans may also be included among models with capitation, all the other forms
of managed care are “non–contracted models”, meaning that providers are not incorporated into
a health insurance plan (Reich et al., 2012).
Until 2007, managed care contracts remained quite uncommon: on average, they did not
arrive to cover the 17% of total population. More precisely, their diffusion differed consistently
among areas: in the north–east German cantons, the percentage of managed care was already
close to 30% in the first years of 2000, while in the Romand cantons this percentage was sig-
nificantly smaller (1–5%). However, since 2007, there has been a larger diffusion of this form
of insurance in all areas of Switzerland. Their growing popularity may be explained also in the
light of a change in the legislation. In fact, until 2007, a revision of the federal law allowed
individuals to have only one exclusive reduction of premiums, choosing between a managed care
plan or a higher deductible. Being the two options mutually exclusive, the majority of insured
opted for a higher deductible, as it allowed for a larger discount. In 2007, a new law made it
possible to combine both saving options (i.e. managed care plan and higher deductible), getting
an even higher reduction on premiums. Pushed by the willingness to save money, a wide part of
the Swiss population has opted for managed care contracts since 2007.
Graph 2.1 is based on administrative data and shows the increasing trend of managed care
plans from 2005 to 2012 (dashed line). In only 7 years, their diffusion grew from 10% to more
than half (56%) of the insured population. The other line represents the decline of contracts
with standard deductible, as we will comment in the next subsection.
Managed care contracts became popular and appreciated both by insured and insurers. They
allow insured to save money on premiums, and insurance companies (and institutions) to contain
health care expenditures. Lehmann and Zweifel (2004) compute that the average treatment costs
of HMO in Switzerland are about 62% lower than in the usual fee–for–service setting. In their
analysis they find that 2/3 of savings (40 percentage points) are due to an increased efficiency and
1/3 of savings (20 percentage points) is due to the self–selection effect. A more recent research
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Figure 2.1: The trends of managed care contracts and standard deductible, from 2005 to 2012.
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Notes: Values from zero to one on the y-axis. Data come from the Federal Office of Public Health (2014).
by Reich et al. (2012) confirms these results for HMO and adds that the efficiency gains due
to the family doctor model is about 15%, while the efficiency gain due to callmed model is less
than 4%. Beck et al. (2010) use another methodology and find that the efficiency gain allowed
by HMO is, on average, only 9%, but they detect a huge variation across HMOs.
Managed care plans are generally chosen by the “good risks”, i.e. young and healthy people
that are normally “cheaper” for insurance companies (Beck, 2004). This suggests that, for the
overall equity of the health care system, these forms of insurance may lead to an increased
inequity in the financing. Being the better–off induced to save money on premiums, they end up
contributing to the total health care financing less than those who choose a standard contract
(who are generally the worse–off and the middle–income class). This phenomenon leads to a more
inequitable financing system. The first set of columns of Table 2.1 shows the share of people
enrolled in the different plans of managed care by income quintiles, for the years 2007 and 2012.
Data are extracted from the Swiss Health Survey, the dataset we use in the analysis. Family
doctor is the most popular managed care plan and is especially chosen by people belonging to
the central income quintiles. The HMO is slightly more widespread among the third, fourth and
fifth quintiles. The shares of callmed and insurance with bonus are, on average, smaller than the
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other plans, the former being widespread quite equally among income quintiles and the latter
being more diffused among the better–off. All in all, the shares of each of the managed care
plans are bigger for 2012 with the only exception of insurance with bonus, which seems to have
slightly reduced its popularity in 2102.
Table 2.1: Share of managed care and higher deductible for income quintiles. Years 2007 and
2012.
Income quintile Managed care Higher deductible
2007 2012 2007 2012
First Insurance with bonus 0.5% 0.2% Ded 1000 CHF 4.8% 5.4%
HMO 2.1% 2.9% Ded 1500 CHF 15.6% 10.6%
Family doctor 9.5% 28.3% Ded 2000 CHF 1.6% 1.5%
Callmed 2.6% 5.1% Ded 2500 CHF 8.4% 8.3%
Second Insurance with bonus 0.8% 0.6% Ded 1000 CHF 5.0% 5.2%
HMO 2.3% 3.0% Ded 1500 CHF 16.4% 13.6%
Family doctor 9.5% 32.4% Ded 2000 CHF 2.7% 3.7%
Callmed 2.1% 6.5% Ded 2500 CHF 9.3% 13.4%
Third Insurance with bonus 1.0% 0.9% Ded 1000 CHF 5.3% 6.0%
HMO 3.4% 4.8% Ded 1500 CHF 16.2% 15.3%
Family doctor 8.7% 32.0% Ded 2000 CHF 2.3% 3.7%
Callmed 2.5% 7.3% Ded 2500 CHF 9.9% 15.4%
Fourth Insurance with bonus 1.5% 1.0% Ded 1000 CHF 6.2% 7.0%
HMO 2.7% 4.9% Ded 1500 CHF 17.6% 15.9%
Family doctor 8.5% 32.2% Ded 2000 CHF 3.3% 5.1%
Callmed 2.4% 6.8% Ded 2500 CHF 12.1% 18.5%
Fifth Insurance with bonus 1.7% 1.1% Ded 1000 CHF 7.6% 6.9%
HMO 3.2% 5.4% Ded 1500 CHF 19.4% 17.9%
Family doctor 7.1% 28.4% Ded 2000 CHF 3.8% 5.9%
Callmed 2.4% 8.7% Ded 2500 CHF 16.9% 25.0%
Notes: The first set of columns reports the share of people enrolled in a managed care contract, by income
quintiles. The second set of columns reports the share of people who chose a higher deductible, by income
quintile. Data are extracted from the Swiss Health Survey for 2007 and 2012. Sample weights are used.
If, on the one hand, managed care contracts are an instrument to save money on individual
premiums for the insured, on the other hand they might also act as a barrier to healthcare access.
Gatekeeping itself, as well as the limited choice of doctors, may, in some cases, discourage people
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to seek care, particularly specialist care. The effect on equity in access is not evident. If managed
care plans were mainly chosen by the better–off, this should not necessarily translate in an average
worse inequity in access. Nevertheless, Table 2.1 does not reveal that managed care model meets
only the preferences of the better–off. Therefore, we cannot exclude that part of the savings may
actually hide an increase in inequity.
It has been demonstrated that in the US people with managed care contracts had lower
ratings of care provided by their primary physician, but no association with a reduced access
to specialists was found (Bambra et al., 2014; Grembowski et al., 2003)4. For Switzerland, no
empirical evidence is available on this issue.
Increasing choice of higher deductible
Driven by the same reason of dealing with the increasing burden of health insurance premiums,
many people opt for another solution: they take themselves part of the risk of becoming sick
in order to get a discount on the monthly premiums. This is possible by choosing a contract
with a higher deductible. With a standard insurance contract5, the level of deductible is fixed
at 300 CHF (about 330 US dollars). Yet insurance companies allow to choose among five other
levels of deductible: 500 CHF, 1000 CHF, 1500 CHF, 2000 CHF or 2500 CHF. The higher
the deductible, the higher is the discount on monthly premium for the insured. Similarly to
managed care contracts, this has become quite a common choice, especially among young and
healthy people, i.e. the categories of people that are generally considered “good risks”. Assuming
that their need for healthcare is small, they are prone to take themselves the risk of being sick
in return for a discount on premium’s amount. The red line of Graph 2.1 shows the percentage
of people insured with the standard deductible of 300 CHF from 2005 to 2012. In only seven
years, this percentage decreased by almost a half, changing from 43% to 23%.
The second set of columns of Table 2.1 shows, instead, the share of insured who chose a
higher deductible in 2007 and 2012. More than the managed care plans, it is evident that higher
deductibles are clearly preferred by the better–off. This holds for all the deductible options and
both in 2007 and 2012. We also notice a larger diffusion of higher deductibles in 2012, with
respect to 2007.
According to the literature, a reduction in the insurance coverage should often reduce the
moral hazard effect (Gardiol et al., 2005; van Vliet, 2004). Nevertheless, a smaller insurance
coverage may also have a negative consequence. It may act as an entrance barrier to health care
services, similarly to being enrolled in a managed care plan. It is true that, if we assume that
4The only exception is represented by the treatment of depression. In this case managed care in the US is
associated with an inequitable access to specialist visits (Steiner and Robinson, 1998)
5We refer to standard contracts for adults and young adults (18–25 years old).
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people are rational, they should choose the best contract for themselves using the information
they have regarding their health status. Those who opt for a higher deductible should be those
for whom it is convenient to have such a contract, i.e., those who do not expect to have a large
need of health care. Nevertheless, it is also true that health is a particular good, not totally
predictable. We cannot assume perfect information of individuals for themselves. Clearly, the
unexpected need for care is not a concern for the better–off, who are willing to pay extra out–
of–pocket expenditures. Different is the situation for the worse–off; it can be that they are
discouraged to go to the doctor, despite their health care needs. Since the share of people in
the lower income quintiles with a higher deductible is not negligible, this option may lead to
increased inequity in access to care.
2.3 Methods: the estimation of inequity in health care services
utilization
Previous research on this topic generally refers to the concepts of horizontal equality and hori-
zontal equity. The former indicates a situation where people with the same economic resources
have equal rates of health care use, while the latter is achieved when people in the same need
for health care show equal rates of health care use. The measure of horizontal equality might
become an index for equity only in the case in which the need for medical care does not vary
with income, which is very unlikely.
The general approach in studying the inequality in health care utilization relies on the com-
putation of the concentration index (CI), which is an extension of the Gini index. People are
ranked according to their income and a concentration curve of the number of doctor consulta-
tions is computed. On the x axis the cumulative percentage of people ranked by their income
is represented, while on the y axis there is the cumulative percentage of the number of doctor
visits. The concentration index is two times the area between the 45–degree line (which repre-
sents perfect homogeneous distribution of the visits according to income) and the concentration
curve. If the index is positive, the health care use is more distributed towards the rich, while
a negative sign suggests that lower income people make a more extensive use of (or have more
access to) the health care services (O’Donnell et al., 2008).
Measuring the degree of horizontal inequity requires the same procedure but the CI is com-
puted on the number of need–standardized doctor consultations.
The standardization is necessary to neutralize the effect of those variables that may influence
the use of health services although they should not be taken into account in deciding the necessary
number of visits. These factors, such as policy variables or personal socio–economic conditions,
may be considered as illegitimate factors in the health care utilization decision process. The
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need–standardized health care use is the level of health care that everyone belonging to a similar
health status should use. We can define it as the legitimate health care use associated to a
determined health status. To get a need–standardized measure of health we use in this paper
the approach proposed byWagstaff and van Doorslaer (2000) known as “indirect standardization”.
The level of (indirectly) need–standardized care for individual i (yˆISi ) is computed according to
the following equation:
yˆISi = yi − yˆxi + y (2.1)
where yi is the actual amount of utilization, yˆxi is the need–expected utilization and y is the
sample mean.
yˆxi denotes for each individual the predicted amount of health care (defined as the health
service utilization) that she would have used if she had been treated like other people with the
same need characteristics. In our analysis it represents, in turns, the number of GP visits and the
number of specialist visits. It is computed starting from the estimation of the following equation:
yi = α+ βln(inci) +
∑
k
γkxk,i +
∑
p
δpzp,i + εi (2.2)
where the health service utilization (i.e. the number of visits) is regressed on a set of variables
including a vector of need variables xk,i, (the logarithm of) income, and a set of non-need variables
(zp,i) that could have had a role in the decision whether to go to the doctor or not. We keep
the actual values of the need variables and we replace the non–need variables – the income and
the vector z – with their sample means, to isolate their effect on health care utilization. We
include in the estimation also the means of these factors to avoid a problem of omitted variable
bias, since they could contribute to explain health care utilization.6 In the end, yˆxi is computed
according to the following equation:
yˆxi = αˆ+ βˆln(inci) +
∑
k
γˆkxk,i +
∑
p
δˆpzp,i (2.3)
The definition of needs relies on the health care that a person, on average, is expected to use,
given some of her personal characteristics such as (generally self–assessed) health status, age and
gender.
We compute the concentration index (CI) of yi to assess the measure of inequality in the
distribution of the actual number of visits. By contrast, the concentration index of the need–
standardized health care use CI(yˆISi ) is a measure of the horizontal inequity and is called hor-
izontal index (HI). Among others, van Doorslaer et al. (2004, 2006, 2000) compute this index
6As a sensitivity analysis, we performed all the computations both with and without the cantonal dummies.
Since we got only negligible differences in the results, we decided to keep them out from our main analysis.
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in a cross–sectional setting. The horizontal index suffers from a general limitation: it relies on
the assumption that, after controlling for the need factors, any other difference in the use is to
be attributed to non–need factors. The predicted value of doctor visits is indeed explained on
the basis of need factors (and non–need factors are set equal to the sample average to neutralize
their effect). This is a strong assumption if we consider the limited number of variables that
are generally available to control for different health needs. In our paper we employ a better
specification of need to mitigate this problem.
In this paper we focus the analysis on the total number of visits, and we also perform a
two–step approach, splitting the probability to go to the doctor and the conditional number of
visits (i.e. the frequency of visits after the first contact occurred). An advantage of this model
is that it is easily interpretable within the framework of “principal–agent model”: the patient
(the principal) decides to seek care and the physician (the agent) decides the level of care she
needs. This interpretation is very suitable for the Swiss context, where the deductible represents
a strong entrance barrier. The decision to consult a doctor for a new episode of care can be
considered as independent from the decision of how much health care to take, once the first
contact occurred.
We use a simple OLS for the estimation of the total number of visits, while for the probability
of visits we run a probit model and for the conditional number of visits we run a negative binomial
model. The general functional form for a non–linear model follows equation 2.4:
yi = G
(
α+ βln(inci) +
∑
k
γkxk,i +
∑
p
δpzp,i
)
+ εi (2.4)
Similarly to van Doorslaer et al. (2004), in the standardization process we set non–need
variables equal to their sample means, by analogy with the linear case.
We compute the concentration index on the basis of a “convenient covariance” formula (Kak-
wani, 1980), namely:
CI =
2
y
cov(y, r) (2.5)
This formula relies on the fact that CI is equal to a weighted covariance between individual
number of visits and individual’s relative rank (i.e. her relative position in the income distri-
bution). Given this relationship, it is possible to get to the following “convenient regression”
formula (Kakwani et al., 1997) of a (transformed) yi on the individual weighted relative rank
(ri):
2σ2r
y
yi = α+ βri + εi (2.6)
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where the coefficient β is equal to CI (O’Donnell et al., 2008), σr denotes the variance
of ri, and the standard error of β is the standard error of the CI. The advantage of using
this formula is the possibility to compute the CI standard errors. To correct standard errors
for heteroscedasticity and autocorrelation we use the Neway–West variance–covariance matrix
(Newey and West, 1994).
It has been noted (Wagstaff, 2005) that when the variable of interest is binary, the limits of
CI are not necessarily -1 and +1. To deal with this problem, we use the Erreygers correction
(Erreygers, 2009) for the estimation of the CI relative to the probability to go to the doctor,
which adjusts the formula by the mean and the bounds of the variable in question. In this way,
we also overcome the risk that the CI depends on the mean of the variable considered. We
compute the Erreygers CI (ECI) according to the following formula:
ECI =
4y
ymax − ymin ∗ CI(y) (2.7)
Decomposition
Concentration index is a useful instrument to compare inequities across time and across countries,
but it does not allow to explain the contribution of each factor associated with the inequity. The
decomposition analysis is, instead, a descriptive tool useful to unravel the relative significance of
each regressor on total inequity, and assess the relative magnitude of each source with respect
to the others. From decomposition we can infer about the association of each factor with the
dependent variable, but we cannot infer a causal interpretation. Decomposition only helps to
shed light on causal association if equation 2.2 has a causal interpretation (van Doorslaer and van
Ourti, 2011). Following the procedure by Wagstaff et al. (2003), we perform the decomposition
analysis to assess the weight of each variable on the total concentration index of inequality. In the
linear case the concentration index may be split in a weighted sum of the concentration indices
of each regressor, where the weights are the elasticities of y with respect to that regressor. The
CI can be rewritten according to the following formula:
CI = (βinc/y)CIinc +
∑
k
(βkxk/y)CIk +
∑
p
(βpzp/y)CIp +GCε/y (2.8)
where y represents the mean of y, xk the mean of xk, zp the mean of zp, GCε is the generalized
concentration index of the error term ε. In this paper we perform the decomposition for the
probability of going to the specialist that we previously estimated through a probit regression.
Therefore we need to adjust the Equation 2.8 for a non–linear model. Similarly to van Doorslaer
et al. (2004), we use the estimates of the partial effects evaluated at the means. We therefore
rely on the following decomposition of CI:
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CI = (βminc/y)CIinc +
∑
k
(βmk xk/y)CIk +
∑
p
(βmp zp/y)CIp +GCε/y (2.9)
where βm, βmk , β
m
p , are the partial effects of each variable evaluated at the sample means.
We are aware of the fact that the decomposition may lead to different results, according to the
different choice of the reference group. Unfortunately this is the inevitable consequence of relying
on a linear approximation. The approximation error is included in the generalized concentration
index of the error term (together with the estimation error).
2.4 Dataset
We use data from the Swiss Health Survey (SHS), provided by the Swiss Federal Office of
Statistics, for the years 2007 and 2012. This is a specific survey addressing health issues on
the Swiss population. It is conducted every five years in the three main Swiss official languages
(German, French and Italian) through assisted telephone interviews (CATI). Individuals are also
required to fill a written questionnaire afterwords. SHS provides weights to make the sample
representative of the Swiss population and to deal with non–response bias.
Our dependent variables are the answers to the question: “How many times have you consulted
a GP/medical specialist in the last 12 months?”
Normally, studies on the inequity of health care use, measure the real health care need
through the self–assessed health status. They often include also a dummy variable to control for
individuals who suffer from a chronic illness or disability (van Doorslaer et al., 2004).
The SHS contains more questions about the health status of individuals and we try to exploit
all the available information. As proxies for the health status, we use the “standard” self–assessed
health status divided in 5 dummies, one corresponding to each health level (very good, good, fair,
bad or very bad), and a dummy for chronic conditions. We also add a set of dummies equal to
one if the individual suffered from some health problems during the last 4 weeks, namely: back
problems, weakness, sleeping problems, and headaches. We include a dummy if individual needed
informal assistance in everyday activities in the last 12 months (available only for 2012) and,
finally, a dummy for obesity (equal to one where the Body Mass Index is at least equal to 30).
Following the standard approach in the literature, we chose to consider age and sex as proxies
for need and to include them in the equation as need–factors. More precisely, we assigned to
each individual one dummy variable according to the sex and the age category (female18–24,
female 25–34, female 35–44, female 45–54, female 55–64, female 65+, male18–24, male 25–34,
male 35–44, male 45–54, male 55–64, male 65+ ).
Several forms of income are available in the SHS. We refer to the household income per
equivalent adult, equalized through the OECD equivalence scale.
38
Among the non–need variables, i.e. variables that may affect health care but do not indicate
need for health care, we include education and marital status, that could increase the probability
to seek care, and activity status that could instead impact on the time price of health care use
(van Doorslaer et al., 2004). We use three dummies relative to education: one if the highest level
of education obtained is compulsory education, one if the highest level of education obtained
is secondary education, and one dummy if the individual got a degree. The dummy marital
status is equal to one if the person is married or if she lives in a registered partnership and
zero otherwise, while we control for the activity status with three dummies (inactive, employed,
unemployed).
We also include in our analysis the variables relative to the choice for higher deductibles and
the other insurance plans’ options. In particular, we add one dummy variable for each different
amount of deductible: 300 CHF, 500 CHF, 1000 CHF, 1500 CHF, 2000 CHF, 2500 CHF. We also
add a dummy for each insurance contract available in the dataset: standard contract, insurance
with bonus, HMO, family doctor, callmed option.
The total number of observations is 18.760 for 2007 and 21.597 for 2012. We drop from the
sample young people up to 18 years old and missing values. We end up with a sample of 16.185
observations for 2007 and 16.449 observations for 2012. We apply cross–sectional sample weights
at the individual level in all analysis.
2.5 Results
We now show the results of the inequity analysis for the GP and for the specialist visits. Results
are presented for the whole of Switzerland and for the three main linguistic areas of the country:
German, French and Italian. Differentiating results for linguistic areas is interesting for two
reasons. First, from a health system point of view: it is worth reminding that Switzerland is a
particular federal state where lower levels of government (i.e. cantons), have large autonomy in
the organization of health care and other aspects of the social security system (e.g. the allocation
of subsidies). Second, from an individual point of view: many of the personal choices depend
also on the cultural influence, which is often specific to each linguistic area. For example, the
individual choice of other forms of insurance than the standard one has been more popular in
the German area, than in the other two. Both these reasons may have an impact on the equity
in health care utilization.
Table 2.2 reports concentration indices of actual visits (CI) and horizontal index of inequity
(HI), computed on the basis of the need–standardized visits.
GP visits seem to be pro–poor distributed (second column) in both years. However, the
concentration index does not take into account the real healthcare needs of people. It is very
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Table 2.2: Inequality (CI) and inequity (HI) in GP and specialist visits for Switzerland. Years
2007 and 2012.
Total visit Probability Conditional number
CI HI CI HI CI HI
GP visits
Year 2007 -0.0777 -0.0321 -0.0028 0.0127 -0.0776 -0.0399
Year 2012 -0.0956 -0.0025 -0.0638 -0.0075 -0.0710 -0.0339
Specialist visits
Year 2007 0.0230 0.0417 0.0441 0.0855 -0.0006 0.0028
Year 2012 0.0110 0.0699 0.0480 0.1159 -0.0106 0.0221
Notes: Inequality and inequity indices computed with an OLS model for the total number of visits, a probit for
the probability and a negative binomial for the conditional number of visits. Significant indices reported in bold
(p–value < 0.05).
likely that GP visits are more concentrated among the worse–off, them being also the less healthy.
To check whether GP visits are pro-poor distributed, we have to look at the concentration index
of the need–standardized number of visits, i.e. the horizontal index (second column of results). It
is significant (although very close to zero) only in 2012, meaning that once standardized for needs,
there is no evidence of pro–poor concentration. If we split the estimation into the probability
of going to the doctor and the conditional number of visits, we find no significant concentration
in the probability neither pro poor, or pro rich. By contrast, the conditional number of visits
is more concentrated among poor people in both years. This result could be explained by the
tendency of better–off people to go to the specialist after the first visit to the GP. This is partially
confirmed by results for specialists, as we find evidence of a pro–rich concentration at least in
the probability of a visit.
The simple distribution of specialist visits does not reveal any evidence of inequality nei-
ther pro–poor nor pro–rich (the coefficient is not significantly different from zero). But the
concentration indices for need–standardized visits are positive, suggesting a pro–rich inequity.
Interestingly, it seems that the pro-rich inequity occurs only in the probability of a specialist
visit. Rich people are more likely to go to the specialist doctor than poor people, but after the
first contact, there is no inequity in the conditional distribution of visits (with the only exception
of German areas that show a pro–rich inequity also in the conditional distribution, as we will see
in Table 2.3). Considering the trend 2007–2012, we find evidence of a strongly increased inequity
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favoring the rich in the access to the specialist. The horizontal index increases by 36% changing
from 0.08 to 0.11. This interesting result may indicate the existence of a sort of barrier for the
worse–off to go to the specialist.7
Let us now discuss the concentration indices for GP and specialist visits in the German,
French and Italian areas, separately. As Table 2.3 shows, we detect that the pro–poor inequity
in the conditional number of GP visits is especially driven by the German regions, both in
2007 and 2012. It is worth highlighting that in both years the French area has an unexpected
pro–rich (albeit not significant) inequity in the probability of going to the GP. If we consider
the concentration of specialist visits, we notice that the need–standardized probability to go to
the specialist is pro–rich distributed for all the three areas. In 2007 this inequity is stronger in
the French area than in the German and Italian ones. In 2012 the three areas converge to a
more similar result, everywhere bigger than the result of five years earlier. When we look at the
concentration index of the conditional number of visits, we find that only in the German area
the conditional number of specialist visits is pro–rich distributed.
If we compare our results to the previous findings for Switzerland (Leu and Schellhorn,
2004), we can claim that the inequity distribution of specialist visits has been following an
increasing trend since 1997.8 To frame Switzerland in an international context, we can refer
to the study by van Doorslaer et al. (2004) where the authors compute the income–related
inequalities in doctor utilization in 12 European member States. Apart from three exceptions
(Belgium, the UK and the Netherlands), on average there seems to be no pro rich concentration
in the probability to see a GP in the European countries. The conditional number of visits is
generally pro poor, instead. Switzerland presents a situation similar to Italy or Greece, with a
non-significant inequity in the probability to see a GP and concentration index of about -0.03 for
the conditional number of visits. As far as the probability of seeing a specialist is concerned, our
analysis shows a value of inequality similar to results for Portugal and Italy and anyway higher,
whereas Austria, Denmark and Portugal perform worse for the level of inequity in the conditional
7Besides the success of managed care plans and higher deductible, it is worth mentioning also another possible
factor of inequity. During the years 2006–2010 some people started to be excluded from the statutory coverage due
to their economic inability (or unwillingness) to pay the insurance premium. In 2006 a reform of the Federal Health
Insurance Act came into force and remained valid until the end of 2010. It stated that insurers could suspend
their coverage of health care services to those who gave up paying the premium. For these people only emergency
health care was guaranteed, with the obvious consequence that going to the doctor when needed (particularly
to the specialist) was much more difficult for them.The number of people excluded from the statutory coverage
largely grew in the years 2009–2011, exceeding the 130.000 units. This may also have brought inequity into the
system. However, this phenomenon does not contribute to explain our results, since the sample we use does not
include these individuals.
8It is worth mentioning that Leu and Schellhorn (2004) use a different specification of the health demand
equation. This makes their results not completely comparable with ours.
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Table 2.3: Inequality (CI) and inequity (HI) in GP and specialist visits for the three linguistic
areas. Years 2007 and 2012
Total visit Probability Conditional Number
CI HI CI HI CI HI
GP visits
Year 2007
German area -0.0928 -0.0488 -0.0101 0.0067 -0.0896 -0.0544
French area -0.0368 0.0091 0.0270 0.0324 -0.0475 -0.0076
Italian area -0.0702 -0.0127 -0.0311 0.0012 -0.0599 -0.0068
Year 2012
German area -0.1015 -0.0024 -0.0726 -0.0136 -0.0739 -0.0399
French area -0.0766 -0.0016 -0.0296 0.0247 -0.0643 -0.0225
Italian area -0.1117 0.0022 -0.0597 -0.0119 -0.0898 -0.0372
Specialist visits
Year 2007
German area 0.0212 0.0402 0.0482 0.0877 -0.0040 0.0011
French area 0.0460 0.0677 0.0589 0.1092 0.0178 0.0203
Italian area -0.0238 0.0301 0.0247 0.0656 -0.0337 0.0006
Year 2012
German area 0.0166 0.0801 0.0537 0.1209 -0.0073 0.0291
French area 0.0249 0.0729 0.0589 0.1199 0.0011 0.0234
Italian area -0.0719 -0.0180 0.0432 0.1167 -0.0901 -0.0587
Notes: Inequality and inequity indices computed with an OLS model for the total number of visits, a probit for
the probability and a negative binomial for the conditional number of visits. Significant indices reported in bold
(p–value < 0.05).
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number of specialist visits. A more recent work by Devaux (2013) computes the inequity index
for Switzerland and other European countries, not included in the previous research. Results
regarding inequity in specialist visits place Switzerland only before Belgium, Poland, Spain and
France.
Decomposition analysis
Looking only at the concentration indices, one could think that the effect of increased inequality
in the probability of going to a specialist in the years 2007–2012, may actually be due to a sort
of entrance barrier for the worse off. Different forms of managed care plans, as well as a higher
deductible, may induce the insured not to go to the specialist, maybe in favor of a less expensive
GP visit. The decomposition analysis may clarify if these forms of insurance and the option for
a higher deductible have a role in the dimension of inequality. Even though it does not allow
to assess any causal relationships, it assign a relative magnitude to each contribution for each
source of inequality (both legitimate and illegitimate). Table 2.4 shows for each variable the
marginal effects obtained from the probit regression, its concentration index and its contribution
in explaining the total inequality, based on Formula 2.9. All the values refer to the the probability
of visiting a specialist.
Before discussing the results obtained from the decomposition analysis, we look at the
marginal effects from the probit regression (first and fourth columns of Table 2.4).
Among the managed care plans, the family doctor is the only one able to reduce the proba-
bility to go to the specialist, but only in 2007. In 2012 the only significant result is given by the
callmed option, but with a positive sign, suggesting that this plan increases the probability of
going to a specialist. The results relative to the higher deductible are stronger and always signif-
icant (with the exception of the deductible equal to 500 CHF in 2007). We find that the higher
the amount of the deductible, the lower is the probability of consulting a specialist. In 2012 a
deductible of 1000 CHF reduces the probability to go to the specialist of 6%, while the effect of
a deductible of 2500 CHF is close to 13%. Results are similar for the two years considered.
Among the other non–need variables, being richer increases the probability of a visit of 11%
in 2012, similarly to having a degree (14%). This suggests that richer and more educated insured
are more likely to go to the specialist than a less educated and worse–off individual with the same
healthcare needs. Also being married slightly increases the probability to go to the specialist.
The opposite is true for being employed (or unemployed in 2012) that reduces the probability of
a specialist visit, compared to being inactive.
Results from the decomposition analysis show that in both years the most important con-
tribution to inequality is given by the income itself, immediately followed by education, which
is strongly pro–rich distributed. A more educated person is likely to be more informed about
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Table 2.4: Marginal effects from a probit regression on the probability of a specialist visit and
results from decomposition analysis. Years 2007 and 2012.
Specialist visits: year 2007 Specialist visits: year 2012
Marg. Eff. CI Contrib. Marg. Eff. CI Contrib.
SAH good 0.0642 0.0003 0.0000 0.0463 -0.0252 -0.0009
SAH fair 0.1024 -0.1110 -0.0026 0.1068 -0.1862 -0.0047
SAH poor 0.1683 -0.0020 -0.0901 0.1877 -0.2514 -0.0021
SAH very poor 0.2456 -0.2862 -0.0008 0.2913 -0.2026 -0.0005
chronic 0.0828 -0.0001 -0.0025 0.1237 -0.0374 -0.0027
back 0.0446 -0.0335 -0.0015 0.0329 -0.0473 -0.0011
weak 0.0350 -0.0508 -0.0016 0.0238 -0.0729 -0.0012
sleeping 0.0416 -0.0089 -0.0003 0.0249 -0.0359 -0.0005
head 0.0078 -0.0444 -0.0003 0.0126 -0.0233 -0.0002
obesity -0.0424 -0.0946 0.0006 -0.0071 0.0001 0.0126
assist - - - 0.1671 -0.0762 -0.0028
female1824 0.4298 -0.2456 -0.0065 0.2487 -0.2009 -0.0037
female2534 0.4814 -0.0481 -0.0040 0.2529 0.0472 0.0015
female3544 0.4222 -0.1891 -0.0206 0.2178 -0.0539 -0.0020
female4554 0.3647 0.0233 0.0017 0.1994 -0.0083 -0.0004
female5564 0.2600 0.1209 0.0067 0.1098 0.0659 0.0011
male1824 0.1443 -0.1898 -0.0016 -0.1664 -0.0538 0.0006
male2534 0.1423 0.1610 0.0032 -0.2736 0.1708 -0.0050
male3544 0.1038 -0.0578 -0.0014 -0.2217 0.0834 -0.0029
male4554 0.1541 0.0740 0.0020 -0.2078 0.0634 -0.0025
male5564 0.1592 0.2283 0.0064 -0.1736 0.1682 -0.0042
male65plus 0.1796 0.0664 0.0025 -0.1044 -0.0446 0.0009
log (income) 0.0779 0.0374 0.0527 0.1082 0.0325 0.0526
marital status 0.0409 -0.0802 -0.0038 0.0311 -0.0283 -0.0009
secondary edu 0.0529 -0.0704 -0.0050 0.0728 -0.0308 -0.0028
degree 0.1035 0.2567 0.0167 0.1371 0.3426 0.0163
insurance bonus 0.0570 0.2237 0.0003 -0.0945 0.2007 -0.0003
HMO -0.0109 0.1149 -0.0001 -0.0092 0.1208 -0.0001
family doctor -0.0660 -0.0473 0.0006 0.0123 -0.0047 0.0000
callmed 0.0345 0.0027 0.0000 0.0690 0.0830 0.0007
ded 500 CHF -0.0041 -0.0127 0.0000 -0.0264 -0.0573 0.0004
ded 1000 CHF -0.0807 0.0919 -0.0009 -0.0612 0.0634 -0.0004
ded 1500 CHF -0.0929 0.0423 -0.0014 -0.0879 0.0830 -0.0019
ded 2000 CHF -0.1039 0.1533 -0.0009 -0.1182 0.1895 -0.0016
ded 2500 CHF - 0.1298 0.1533 -0.0044 -0.1287 0.1837 -0.0067
unemployed 0.0010 -0.0493 -0.0016 -0.1130 -0.2993 0.0000
employed -0.0491 -0.0986 -0.0062 -0.0440 0.0539 -0.0038
residual -0.0059 0.0006
Notes: The first and the fourth columns show the marginal effects from a probit regression on the probability of
consulting a specialist. The second and the fifth columns (CI) report the concentration indices, while the third
and the last column report the contribution to inequality. Significant indices reported in bold (p–value < 0.05).44
the overall health care system features and also about her health problems. Thanks to her in-
formation advantage, she may decide herself to go directly to the specialist without passing first
through a GP.
All forms of managed care plans summed together give a contribution to inequality close to
zero, both in 2007 and 2012. It means that they do not have a role in increasing inequity in
access to care.
Summing together the contributions to inequality of the higher deductibles, we get a value
equal to -0.0075 in 2007 and equal to -0.0103 in 2012. Therefore, the total contribution of this
option is bigger in 2012, and it has a negative sign in both years. This means that the total
contribution of higher deductible in explaining inequity is actually significant, but it goes in an
unexpected direction. This option reduces inequity instead of increasing it.
Our results can be explained if considered together with the distribution of these forms of
insurance among income quintiles (see Table 2.1). As already remarked in Section 2.2, higher
deductible have found more success among richer people and in 2012 even more than in 2007 (with
the only exception of deductible equal to 500 CHF that is pro–poor distributed, on average).
Therefore, on average, a higher deductible may act as en entrance barrier more for the better–
off than for the worse–off. It is likely that a high deductible prevents insured from going to the
doctor when is not needed and the effect is stronger, the higher the deductible. A high deductible
seems then to have a very positive effect. It seems to be effective in avoiding unnecessary care,
reducing moral hazard behaviors. Moreover, it does not seem to be responsible for the worsening
of equity in access, on average.
However, we also have to mention that people in the first quintile often receive a public
financial aid (earmarked subsidy), thus they do not have an interest in getting a discount on
premiums. This is a particular feature of the Swiss healthcare system, essential to explain our
results. If the worse–off could not rely on a subsidy, many more individuals belonging to the
first income quintile would have likely opted for a plan with a discount on premiums. In this
scenario, the contribution to inequity of managed care and high deductible might have been
different. Unfortunately, SHS data does not collect information on financial subsidies, therefore
we cannot include it in our analysis.9
To sum up, our findings suggest that the choice of a higher deductible acts as an entrance
barrier for insured, as expected. Nevertheless, being them more widespread among the better–off,
this barrier prevents from going to the specialist more people belonging to the middle–rich income
9We computed the decomposition analysis on a subsample of individuals, as robustness check. We dropped
from the sample the individuals belonging to the first income quintile, as a proxy for those receiving the earmarked
subsidy. For the managed care plans we get results similar to the main ones, while the contributions to inequality
of higher deductible maintain a negative sign, but their relative magnitude slightly decreases with respect to the
main results. Therefore, our results are robust even though we are not able to control for the subsidies.
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class. This option seems to have two positive effects. First, it rebalances the concentration of
visits towards a smaller pro–rich inequity and second, it discourages moral hazard behaviors. On
the contrary, our analysis does not reveal any contribution to inequality due to being enrolled in
a managed care plan, neither in 2007, or 2012.
2.6 Conclusion
In this paper, we focus on the inequity in doctor utilization in Switzerland in 2007 and 2012.
This spell of time coincides with a larger diffusion of managed care plans, as well as contracts
with higher deductible. Both these options allow insured to get a discount on monthly premium.
Managed care comes at the cost of less freedom of choice, while a higher deductible provides less
insurance coverage. We aim to assess whether these forms of insurance may be responsible for
an increased horizontal inequity in the health care utilization.
We investigate this topic empirically, computing the concentration indices of actual and need–
standardized number of GP and specialist visits. We do this for the total number of visits, for
the probability to seek care and for the conditional number of visits. Results suggest that, in line
with previous literature, there is evidence of a pro–rich inequity in the distribution of specialist
visits. Moreover, this inequity strongly increased in the five years considered, growing from 0.04
to 0.07. This increase is mostly reflected on the probability to go to the specialist. In all the
three linguistic areas, the probability to go to the specialist is very inequitable, reaching values
that are among the highest in the European context.
We also perform a decomposition analysis, which assigns to each factor a magnitude of their
contribution towards inequity. We find that inequity in the distribution of specialist visits is
mainly due to income and educational attainment.
Our results are an interesting contribution to assess to what extent managed care and the
higher deductible impact on inequity in health care services utilization. The role that managed
care plays on total inequality is close to zero. We get different results as far as the contribution of
a higher deductible is concerned. This has a significant weight in the decomposition of inequality
in access, but in the opposite direction. A higher deductible seems to mitigate the inequity in
the distribution of specialist visits. This is due to the fact that this option is more widespread in
the group of “good risks”, who generally belong to the middle–high income class. Furthermore,
the worse–off often get an earmarked subsidy, so they have no incentive to enroll in a plan that
guarantees a discount on premiums. Therefore, we find that the plans with a high deductible
seem to reduce the inequity in access to care. Moreover, managed care and higher deductible
are even likely to reduce the moral hazard effect, preventing people from going to the specialist
when is not really needed. The increased inequity in access seems to be mainly due to a much
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larger contribution of education in 2012 than in 2007.
This work presents some limitations. Results from the decomposition analysis help to shed
light on the role of the different insurance plans on total inequality, but do not explain why we
observe a worsening in the equity in the access to specialist visits. Our analysis does not consider
the evolution of income distribution over time, nor the price of specialist visits. Both are factors
that may have an impact on equity. Further research on this topic would be needed.
Equity in access is a principle valid in itself and it is even more significant if considered as
a necessary step to reach the ultimate principle of equity in health. In this paper, we do not
assess the trend in inequality in health for the years 2007–2012. It may be that more educated
people get the best treatments by the best specialists and this might translate in a better health
outcome for them. There is space for research to investigate whether and to what extent the
inequities we found translate into inequities in health outcomes.
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Chapter 3
Short term effects of public smoking
bans on health
Keywords
Smoking ban, AMI, ETS, health inequality.
3.1 Introduction
The negative effects of smoking—both primary and second hand—are well known and subject
of many studies. In a recent review study, Cawley and Ruhm (2011) show that smoking is the
most important modifiable risk factor related to both mortality and disability and the most
damaging health behavior in high-income countries. A recent report by the American Hearth
Association (Go et al., 2014) estimates a total cost associated with smoking of $193 billion
per year, 50% due to direct medical costs and 50% due to productivity costs. Smoke also
contributes to health inequality since smoking prevalence and environmental tobacco smoke
(ETS) exposure1 are higher among people from low socio-economic status (SES) (e.g. Cutler
and Lleras-Muney (2010)). The public awareness about the large negative effects of smoking
induced several governments all over the world to enact a series of measures to reduce tobacco
consumption and ETS exposure. Among them, smoking ban in public places is one of the
most important public health intervention implemented in many developed countries in the last
decades. However, several concerns have been raised—in particular among economists (e.g.
Adda and Cornaglia (2010))—about the real health benefits deriving from this public health
intervention.
This paper investigates the short term effect of public smoking bans on the incidence of acute
1In this paper ETS refers only to second-hand smoke, namely being exposed to someone else’s cigarette, cigar,
or pipe smoke.
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myocardial infarction (AMI), which represents the main cause of death in almost all OECD
countries (OECD 2013). In particular, exploiting the time and geographical variation in the
introduction of smoking ban in public places in Switzerland, we show that the incidence of AMI
decreases on average by about 10-12% immediately after the law implementation with large
heterogeneity across population sub-groups. Moreover, using this quasi-natural experiment, we
provide evidence of a causal association between ETS and AMI.
Previous economic studies mainly analyze the effect of smoking ban on smoking behavior,
while they are limited in the ability of studying the effects of smoking bans on objective health
outcomes. This might be explained by the fact that the negative effects of smoking on most of
the associated diseases may generally require long times of observation.
For instance, the effect of smoking on lung cancer may be detected only in the long run. A
change in smoking behavior —such as the individual decision to quit smoking— is, by contrast,
easier to measure. Therefore, it often represents the only feasible outcome to assess the effect of
the anti-smoking policy in the short run. However, the evidence from these studies is quite mixed.
In the US, Evans et al. (1999) show that smoking ban on workplaces reduced smoking prevalence
by 5%. On the other hand, Adda and Cornaglia (2010) report evidence of displacement of ETS
from public to private places and no effect on smoking prevalence. In Canada, (Carpenter et al.,
2011) find that these policies had no effect on smoking prevalence, but induced large reduction
in public-places ETS exposure without any private displacement. The introduction of smoking
bans in public places had limited or no effects on smoking prevalence also in Germany (Anger
et al., 2011) and UK (Jones et al., 2013), while there is contrasting evidence regarding Italy
(Bono et al., 2014; Buonanno and Ranzani, 2013). Given the well-know negative association
between smoking and body weight (e.g. Cawley et al. (2004)), some studies evaluate the effect of
this policy also on other health behaviors, showing some evidence of weight gains and increasing
alcohol consumption after the introduction of the smoking ban in Italy (Pieroni et al., 2013) and
in the US (Liu et al., 2010). All in all, the risk of negative spillovers on other behaviors, together
with the evidence of displacement from public to private places, might explain the previously
mentioned concerns about the health benefits of this policy.
We contribute to the literature by focusing on AMI hospitalizations, which allow us to mea-
sure the short-run effects of smoking bans on an objective metric of health. A wide strand of
the literature argues that smoking is the most important avoidable cause of coronary diseases
(Glantz and Parmley, 1991). In particular, several studies show that it is associated with a
greater risk of AMI, especially among men (Teo et al., 2006). From a medical point of view,
exposure to smoke is associated with an endothelium-dependent dilatation, which may lead to an
early arterial damage (Celermajer et al., 1996), as well as a tendency towards an acute enhanced
platelet aggregation (Sargent et al., 2004) and reduced health variability (Pope et al., 2001).
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All these factors occur rapidly, within 30 minutes after exposure to smoke, increasing the risk
of myocardial infarction (Barnoya and Glantz, 2005). At the same time, these acute negative
effects disappear in a few hours after the end of the exposure (Argacha et al., 2008). Therefore, a
reduction in the number of AMIs should be quantifiable immediately after the introduction of the
smoking ban, starting from the initial days after the reduction of smoking exposure (Richiardi
et al., 2009). This means that we can evaluate the short-term effect of this policy.
We are fully aware of the previous epidemiological literature investigating the effect of smok-
ing bans on cardiovascular diseases. For instance, in a meta-analysis of the existing litera-
ture, Meyers et al. (2009) argue that after the implementation of the smoking ban, AMI risk
decreases by 17% overall, with a bigger effect among younger individuals and non-smokers.
However, there are fundamental concerns regarding the identification assumptions behind the
estimation strategies implemented in these studies. Most of them are based on a simple pre and
post comparison in a single city or country (e.g. Di Valentino et al. (2011) on the Swiss canton
Ticino), without accounting for all potential confounders, such as preexisting trends or the effect
of contemporaneous policies. To this end, Shetty et al. (2011) find that the relationship between
smoking bans and AMI in the US is sensitive to the choice of the city and specification. For
instance, using data about US-Medicare enrollees aged 66+ for the years 1999–2008, Barr et al.
(2012) show that the negative effect of smoking bans on AMI hospital admissions disappears as
they account for non-linear adjustment for secular trend and random effects at the county level.
Finally, some of these studies evaluate the effect of smoking bans in very small cities and this
may lead to problems of external validity of their results (e.g. Sargent et al. (2004)).
In our estimation strategy we address all these concerns. In particular, we exploit the Swiss
quasi-natural experiment to assess empirically whether there is a causal effect of the smoking
ban on AMI hospitalization. Switzerland is a perfect environment to study, since the 26 Swiss
cantons implemented the public smoking ban at different points in time, making it possible to
exploit both time and geographical variation. We use monthly data on the universe of Swiss
hospitals admissions observed from 2004 to 2012, broken down by age and sex. This allows us to
evaluate the heterogeneity of our results. In particular, the reduction in AMI hospitalization has
been larger in absolute terms for men aged 50–65 and 66+, while we find some effects only on
women 66+, the only subgroup among women at risk of AMI. It is worth noting that in relative
terms (compared with the mean incidence of the disease in the population) the larger effect is
found among men under 66 (both under 50 and 50–65). To explain such result, we use survey
data from the Swiss Household Panel showing that younger people are more likely to go to bars
and restaurants and so more exposed to ETS before the policy implementation. Such intuition
is corroborated by self-reported information on ETS exposure, that we extract from the Swiss
Health Survey, that show a large age gradient in ETS exposure in 2007 before the policy was
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enacted.
Even more interesting is the evidence we report of a dramatic drop in the average ETS
exposure in 2012 (after the implementation of the policy) that was not followed by any reduction
in smoking prevalence and cigarette consumption. This interesting result —consistent with most
of the literature so far mentioned— suggests that the reduction in AMI hospitalization is only
due to a reduction in ETS exposure and not to a reduction in smoking consumption. After all,
the reduction of ETS exposure, and its negative consequences (i.e. AMI), represents the main
goal of the policy, while the reduction of smoking prevalence and consumption might be at most
considered a potential positive spillover. Hence, we believe that our paper can better evaluate
the effectiveness of this kind of policy than most of the previous economic literature that only
analyzes its effects on smoking prevalence and consumption.
In our analysis we also exploit the residential information on the hospitalized patients to
evaluate the heterogeneity of our results across smaller areas (106 smaller geographical units)
with different level of income and education, holding constant the confounding effect of different
institutional settings at cantonal level. In particular, we find that the effect of the policy on
AMIs has been stronger in low income and low education areas. As before we use survey data on
smoking prevalence and ETS to explain our results. As expected among low SES people, there
is the largest incidence of both smokers and the largest (self-reported) exposure to ETS.
We evaluate the robustness of our results to alternative model specifications. In our estima-
tion strategy we account for many factors that might confound our results, such as area (canton
or region) and time fixed effects, as well as area specific time trends. We also control for local
unemployment rate to take into account the well-know pro-cyclical behavior of smoking and
AMIs (Ruhm, 2005, 2007) and to take into account the effect of the last financial and economic
crisis.
We indirectly test our main identification assumption by checking whether the policy also
affected the incidence of lung, prostate and breast cancer which are known not to have been
affected by the policy in the short run. We also show that the reduction was larger during the
winter period, when people are more likely to seat inside public places. Moreover, we implement
a “placebo” test (by using one year lag and lead values for the treatment) to assess concerns about
the potential endogeneity of the policy (Carpenter et al., 2011) and to rule out the possibility of
other confounders or external shocks driving our results.
Our results are particularly relevant from a health policy perspective. First they shed a light
on the doubts raised by previous literature on the effectiveness of this policy. We report evidence
of large positive benefits on health already in the short-term, by showing a reduction in AMI
incidence, the most important cause of death related to ETS together with lung cancer. Second,
our results suggest potential benefits also on health inequality, since we show that the ban had
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stronger effects in areas characterized by lower SES (low income and education).
The next section describes how and when the smoking bans were implemented in the Swiss
cantons. Section 3.3 presents the data and some descriptive evidence. Section 3.4 explains the
choice of the model and discusses some empirical issues. Section 3.5 shows and compares our
main results and introduces some robustness checks. Finally, section 3.6 concludes.
3.2 Swiss institutional setting
Smoking bans in Switzerland were implemented only after a long series of anti-smoking initiatives
undertaken some years before and mostly defined at federal level. In 2001 the Swiss Federal
Council adopted the National Tobacco Control Program, aimed at sensitizing people towards
the bad effects of smoke and at changing smoking behavior. The Program devoted economic
resources for anti-smoking campaigns and other measures and was meant to last until 2005, but
it was extended until 2008 and subsequently until 2016 (under the new name of National Tobacco
Program). To guarantee the necessary economic resources for anti-tobacco initiatives, in 2004
the Federation set up also the Tobacco Control Fund, financing it through a tax of 2.6 centimes
on each cigarette packet sold. It supported measures aimed to assist people who wanted to give
up smoking and to protect non-smokers against second-hand smoke. It was in this setting that in
April 2007 canton Ticino (TI) decided to implement a smoking ban in all public places (i.e. bars,
restaurants and clubs), with the aim of contrasting smoke and protecting the population against
second-hand smoke. Ticino was the first canton opting for such a policy. Canton Graubunden
(GR) followed Ticino one year later.
In May 2010 a federal law regarding the implementation of the smoking ban came into force
(it was enacted already in October 2008): smoking in bars and restaurants was prohibited in
each canton. The federal law was less restrictive than the one approved in canton Ticino. It
allowed restaurants to have some rooms for smokers, and even the service may be guaranteed
in some cases. However, cantons were free to set the federal law only as a lower bound and to
choose more restrictive regulations. Anticipating the implementation of the federal law, most of
the other cantons adapted and introduced the public smoking ban during 2009 and 2010. The
last canton to introduce the ban was Appenzell O.Rh. (AR) at the beginning of 2011.
Table 3.1 shows for each canton (first column) when the smoking ban in public places started
to be in force (second column) and the strictness of the law that they chose to adopt (third
column).
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The majority of cantons decided for a more severe regulation, meaning that they chose not
to dedicate special rooms for smokers. It is worth remarking that there seems to be a sort of
“linguistic” trend in the timing of smoking bans implementation: the Italian speaking cantons
were the first cantons to implement this policy, followed by most of the French speaking cantons
and lately, by the German speaking cantons. It is likely that the choice of a canton whether to
implement the smoking ban was also affected by the choice of neighbor territories, both Swiss
and non-Swiss.
Finally, it is important to stress that only the smoking ban in public places was set at cantonal
level, while all the other anti-smoking policies, such as the excise tax, were set at federal level.
3.3 Data
Administrative data
Our main analysis is based on data from the “Swiss Hospital Statistics” (HOST), provided by the
Swiss Federal Statistical Office. It is a wide dataset collecting information on each patient for
the universe of the Swiss hospitals from 1999 to 2013; after 1998, it became compulsory for each
hospital to participate at this statistics. HOST includes basic demographic information (age,
sex and residence) for each patient, and information on the main diagnosis, as well as secondary
diagnoses. For our analysis we use data from 2004 to 2012, due to the lack of some hospitals’
data for the years before 2004. Since the dataset is based on individual data, we are able to ex-
plore the heterogeneity across different classes of population by carrying out separated estimates
for different groups of patients (according to age and sex). Concerning patient’s geographical
residence, Switzerland was split in more than 700 geographical regions called “Medstat regions”:
each of them counting from 3.500 to 10.000 inhabitants and including territories similar from
a socio-economic and geographical point of view. In 2008 the Swiss Federal Statistical Office
implemented a major redefinition of the Medstat regions, changing substantially the agglomera-
tion of municipalities that form each region. The rationale behind this redefinition was to have
more homogeneous and comparable areas across the country. Unfortunately, for the aim of our
research, this change does not allow us to analyze the impact of the smoking ban policy at this
geographical level because the same areas are not comparable before and after the redefinition.
For this reason, we consider two other geographical levels for our analysis: the 26 cantons and the
so-called “Spatial Mobility” (SM) regions, 106 geographical units that are smaller than cantons
but larger than the Medstat regions.2
2Knowing the zip codes grouped in each Medstat and in each SM region, we are able to group the Medstat
regions into the larger SM regions. Nevertheless, in some cases the Medstat regions cannot be uniquely assigned
to one SM region. In these cases we split the number of AMIs of the Medstat region and we assign it to the SM
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Table 3.1: Implementation of smoking bans (SB) in the Swiss cantons
Canton SB implemented in More severe regulation
AG 05.2010
AI 05.2010
AR 01.2011 X
BE 07.2009 X
BL 05.2010 X
BS 04.2010 X
FR 01.2010 X
GE 11.2009 X
GL 05.2010
GR 03.2008 X
JU 05.2010
LU 05.2010
NE 04.2009 X
NW 05.2010
OW 05.2010
SG 07.2010 X
SH 05.2010
SO 01.2009 X
SZ 05.2010
TG 05.2010
TI 04.2007 X
UR 09.2009 X
VD 09.2009 X
VS 07.2009 X
ZG 03.2010
ZH 05.2010 X
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Carrying out the analysis at cantonal level is an advantage because it coincides with the
political area of the introduction of the smoking bans. On the other hand, focusing on the SM
regions (hereafter regions) allows us to exploit the heterogeneity of the effect across income and
education levels (see also Section 3.4) holding costant the effect of institutional factors at cantonal
level. To be able to exploit these potential sources of heterogeneity, we added to our dataset some
socio-demographic information: population, income, education and unemployment rate. Data
on population for cantons and municipalities are provided by the Swiss Federal Statistical Office.
We aggregate data of municipalities to obtain data at regional level. However, the population
breakdown by sex and age is available only for cantons, while for municipalities this information
is provided only in the 2000 census. To obtain a proxy of the regional population by age and
sex for the years 2004–2012, we multiply the value of the regional population of the year 2000
(from the municipal census) for the rate of variation of the population of the canton to which
the region belongs. We do this for each age and sex category.
Monthly data is available only for unemployment rates, while for income and education we
have data only for few years. We extract data on unemployed from the website of the State
Secretariat for Economic Affairs (sector of job market statistics) for the years 2004–2012. Data
is taken from the official registers of unemployed. It is monthly updated and available both at
cantonal and regional level.
Data on education is available in the Statistical Atlas of Switzerland for the year 2000. For
each region we compute the share of people with only compulsory primary education, the share
of people with a degree of second level (high school) and the share of people with a degree of
third level (college). Finally, we use data on income from the Swiss Federal Tax Administration
website for the year 2000–2010.3
Survey data
In this paper we also use survey data from the Swiss Health Survey (SHS) and the Swiss House-
hold Panel (SHP) to investigate smoking habits, ETS exposure and life style of various subgroups
of the population.
The SHS was meant to provide measures of the Swiss population’s health status and health
behaviors. The SHS has been carried out once every five years since 1992 by the Federal Statis-
tical Office (FSO). The last survey took place in 2012 as part of the data collection programme
of the Swiss population census. The survey is carried out in German, French and Italian using
regions to which the Medstat region belongs. We use as a weight the number of zip codes of the Medstat that
belong also to the SM region divided by the total number of zip codes that compose that Medstat.
3We cannot insert the income in our estimation as a time varying variable because up to now the last available
year is 2010. For this reason we use a mean of the median income in each region in the period 2004–2010.
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computer assisted telephone interviews (CATI) followed by a written questionnaire. The target
population consists of the resident population in private households aged 15+. Overall, 11’314
women and 10’283 men were questioned. The survey provides sample weights to take into ac-
count the sample design and non-response. See OFS (2013) for additional information on the
survey design and methodology. From the 2007 and 2012 survey of the SHS, we extract infor-
mation on smoking behavior (smoking prevalence and cigarette consumption) and ETS (average
minutes of passive smoke per day) broken down by education and age.
The SHP constitutes a unique longitudinal database for Switzerland. The survey covers a
broad range of topics including information on leisure time and life style that we use to investigate
who are the people that are more likely to attend public places (i.e. bars, pubs and restaurants)
and so more likely to be affected by the smoking ban policy. Data collection started in 1999 with
a sample of 5,074 households containing 12,931 household members. A refreshment sample was
added in 2004 and since 2013 the SHP contains a third refreshment sample of 4’093 households
and 9’945 individuals. See Voorpostel et al. (2014) for additional information on the SHP.
3.3.1 Descriptive statistics and graphical evidence
Table 3.2 shows in the first two columns the monthly average and standard deviation of AMI
hospital admissions for the whole population by area and by sex in the years 2004–2012.
In the third column we report the corresponding incidence per 100’000 inhabitants by dividing
the number of AMI cases in each canton for the corresponding population. Similarly, the last
column reports the incidence based on regions. Consistent with the medical literature, two thirds
of the AMI hospital admissions are men, in particular among those in the age class 50–65 and
66+, while for women the incidence of AMIs is almost only among women aged 66+. There
is evidence of substantial variability in the number of AMI hospital admissions not only across
cantons but also over time. We observe an increasing trend in AMI hospital admissions over
the years under investigation: this may depend on better measures of prevention, on better
access to health care and on changes in the definition of the diagnosis, especially after a recent
reclassification of some angina patients into AMI cases (Insam et al., 2013). We crosschecked
our dataset with data from the AMIs Plus – the National Registry of AMI in Switzerland – and
we confirmed the consistency of HOST data and the presence of the increasing trend. There
is also evidence of seasonality with a larger incidence of AMI during the holiday season. This
descriptive inspection suggests that taking such spatial and time heterogeneity into account in
our estimation strategy is crucial. HOST collects about 90% of the total estimated number
of AMI cases: the remaining 10% are people who die from AMI before arriving to the hospital
(Meyer et al. (2007) perform this estimation for the year 2004). This small percentage is expected
to further decrease over time, due to the easier access to hospitals in many areas. Notice that the
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Table 3.2: Average number of AMI hospitalizations per month at cantonal and regional level and
incidence per 100’000 inhabitants, by age and sex
CANTONAL VALUES REGIONAL VALUES
# AMIs (S.D.) Incidence # AMIs (S.D.) Incidence
All
Total 29.556 (31.328) 10.094 7.250 (7.544) 10.324
Under 50 3.580 (4.266) 1.798 0.878 (1.316) 1.882
50–65 8.654 (9.752) 15.721 2.123 (2.524) 15.629
66+ 17.321 (18.557) 37.630 4.249 (4.758) 37.874
Men
Total 20.227 (21.598) 14.124 4.961 (5.242) 14.366
Under50 3.069 (3.733) 3.022 0.753 (1.186) 3.165
50–65 7.032 (8.006) 25.481 1.725 (2.124) 25.169
66+ 10.126 (11.007) 55.150 2.484 (2.908) 52.020
Women
Total 9.329 (10.291) 6.182 2.288 (2.826) 6.335
Under 50 0.511 (0.941) 0.530 0.125 (.395) 0.553
50–65 1.623 (2.204) 5.941 0.398 (.781) 5.835
66+ 7.195 (8.061) 25.604 1.765 (2.312) 26.988
N 2808 11448
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Figure 3.1: Discontinuity in AMI hospital admissions after the smoking ban by sex
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mean incidence of AMI hospitalizations is slightly larger at regional level than at cantonal level.
This difference arises because the cantonal mean gives the same value to all cantons, regardless
of the population’s size. By contrast, the mean incidence at regional level is closer to the true
national value.
In Figures 3.1 and 3.2, we show first evidence of a statistically significant discontinuity in
the number of AMI hospital admissions at national level in correspondence of the smoking ban
implementation for men but not for women.
Since each canton implemented the policy at different points in time, we aggregate AMI cases
across different cantons based on the distance in months from the policy implementation, as in
a sort of Regression Discontinuity Design (RDD). More specifically, in Figure 3.1 we show the
raw data, while in Figure 3.2 we report the aggregate residuals from a regression in which we
control for year and canton fixed effects. This second figure is meant to take into account the
time and geographical heterogeneity described before. The vertical line represents the “month
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Figure 3.2: Discontinuity in AMI hospital admissions after the smoking ban by sex (residuals)
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zero”, namely the month during which each canton introduced the ban. Purely for descriptive
purposes, the fitted lines are based on a quadratic fit on the two years before and after the
implementation of the policy, while the shaded areas correspond to the 95% confidence interval.
For men, Figure 3.1 already shows evidence of a discontinuity in AMI cases after the intro-
duction of the smoking ban, although we are not controlling for temporal trends and cantonal
differences. This discontinuity is confirmed in Figure 3.2, where we take into account these po-
tential confounding factors. In particular, the residuals are slightly above zero in the two years
before the discontinuity, while they rapidly decrease towards –40 in the months immediately
after the smoking ban implementation. For women, instead, we do not have evidence of any
discontinuity at the cut-off date.
Unfortunately, we are not able to show similar evidence for cantons since the number of AMI
cases each month is too small to show graphical evidence of a significant discontinuity. In the
next section, we investigate the effect of smoking bans on AMI hospitalizations trying to take
into account all the potential factors that might confound the effect of the policy. It is worth
reminding that, since Figure 3.2 nets out canton and time fixed effects, we are already controlling
for the most important confounding factors in the relationship under investigation.
3.4 Empirical strategy
The empirical strategy exploits the geographical and time variation in the implementation of
the smoking ban. In the analysis that follows, the outcome of interest is represented by the
AMI incidence rate, AMIkt (as reported in column 3 of Table 3.2), that is obtained dividing the
absolute number of patients hospitalized for AMI in area k (it can be either canton or region)
and at time t by the corresponding population of the area k at time t. We prefer this variable
to the absolute number of AMI cases because it allows us to control for the different dimension
(and population structure) of our Swiss regions. Moreover, it nets outs the effect of differential
population trends across regions.4 More specifically, we estimate the following equation:
AMIkt = β0k + β1SBkt + β2Xkt + δt + f(k, t) + kt (3.1)
where SBkt is a dummy equal to one if the smoking ban was enacted in area k at time t; the
coefficient β1 measures the effect of the policy. Our specification also includes area, β0k, and
time, δt, fixed effects and, as additional robustness check, area specific time trends, f(k, t). More
specifically, we model the function f(k, t) as a linear function (i.e. multiplying the geographical
dummies for a linear time trend). Finally, Xkt includes monthly data on unemployment rate.
4The other advantage of using the incidence rate is that we can rely on linear regression models and avoid the
issue of estimating count data models.
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Ruhm (2005, 2007) show that both smoking and AMI discharges are pro-cyclical, so we might
expect a negative correlation between unemployment and AMIs.
Time is measured in months (108 months starting from January 2004 to December 2012). As
already mentioned in Section 3.3, the geographical unit under investigation, the area k, can be
either the canton or the region. Since the policy is implemented at cantonal level it is natural to
consider the canton as the reference geographical unit. However, we believe that it is still worth
focussing the analysis on a smaller geographical area for two main reasons. First, it allows to
analyze the heterogeneity in the effect of interest across educational and income levels, holding
constant the confounding effect of institutional differences at cantonal level. In other words, the
analysis at the level of regions exploits the geographical variation within cantons in the level of
education and income. Second, the increase in the number of observations allows us to increase
the power of our estimation strategy and to reduce the relative weight of smaller cantons. As
discussed in Section 3.3.1, the analysis at cantonal level put the same weights to cantons of
different dimensions.5
Given the panel nature of the dataset, the baseline estimation method for this model is the
within estimator (fixed effects), which allows to remove all time-invariant confounders at area
level. Our estimates are separated by sex and age group (below age 50, age 50–65 and age 66+) to
take into account the large differences in the incidence of AMIs across these population subgroups.
We also implement separated estimates according to the severity of the policy implemented by
the different cantons (severe vs. mild policy, see Section 3.2 for further details).
3.4.1 Identification issues
As discussed throughout the paper, the identification of the effect of the smoking ban on AMIs
comes from the time and geographical variation in the implementation of the policy across
cantons. Notice that different from a standard “diff-in-diff” strategy, we do not need the classic
common trend assumption, since the policy has been implemented in all cantons but at different
points in time. Therefore, it becomes crucial that there are no other policy changes or cantonal
shocks coinciding with the introduction of the smoking ban and affecting the number of AMIs.
The specification proposed in equation (3.1) should be sufficiently flexible to account for the
potential confounding factors at geographical level since it also includes area specific time trends.
In addition, our specification includes local unemployment rates to address the concern that the
policy implementation is somewhat contemporaneous with the last financial and economic crisis.
However, this is unlikely since the policy implementation has a very large temporal variation
5As robustness check we implemented our cantonal estimates using weights based on population size. The
results we found are slightly larger than those reported in the main text and so very close to the effect estimated
using the regions.
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that does not coincide with the timing of the crisis (2008–2009).
More generally, we believe that it is very unlikely to have any confounding factors correlated
with the policy implementation in each canton and able to affect the number of AMIs at the same
time. Unfortunately, we cannot test it directly, but we implement a battery of robustness checks
that supports our identification assumption. First, we implement a sort of “unconfoundedness
test” in which we test whether the policy had an effect also on the incidence of lung, prostate
and breast cancer, that should not be affected by the policy in the short run. Second, as in
Carpenter et al. (2011), we implement a placebo test in which we assess concerns about the
potential endogeneity of the policy by controlling for one year–lead of the smoking ban. Such a
test is implemented to verify whether we are confounding the effect of the smoking ban law with
other unobservable trends that vary across cantons and in particular whether “ large shocks to
outcomes systematically precede rather than follow” smoking ban laws.6 We test for the presence
of jumps in the AMI hospitalizations distribution one year lag and lead the real implementation
of the policy in each canton. Another robustness check we implement is to check whether the
effect of public smoking ban is larger during the winter season. The intuition is that during
these months people that go to pubs and restaurants are more often inside public places because
of the adverse weather conditions. Whereas during the other seasons people should stay more
often outside drinking and eating and so they should be less exposed to ETS. So, if we are not
confounding the effect of the ban with that of other factors, we should observe a larger reduction
in AMIs during the winter season.
Even tough all these tests support our identification strategy, some concerns may still arise
regarding the estimation of the standard errors, since in panel data errors are often correlated
both across time and regions. In this case it might not be sufficient to cluster standard errors only
at the statistical area level (as suggested by Bertrand et al. (2004)). It is indeed very likely that
the number of AMI cases is correlated also spatially across cantons. The decision of one canton
to introduce a smoking ban may have an influence also on the choice of a neighbor canton. In our
case, it is quite evident that the timing in the implementation of the policy is somewhat affected
by some geo-cultural factors. In particular, Ticino was the first canton to implement the policy
in 2007 (probably affected by the Italian smoking ban implemented since 2003), followed by
Graubunden (always at the border with Italy and with a quite large Italian community). Then,
the policy has been implemented since mid 2009 in most of the French cantons, while most of
the German cantons implemented the policy only starting from 2010. This geo-cultural factor
in the timing of the policy implementation should not affect the estimated effect of the smoking
bans since we control for both canton fixed and canton specific trends. However, such spatial
correlation might affect the standard errors of our estimates. To account for this second potential
6Carpenter et al. (2011) page 49.
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source of correlation we use a two-way clustering strategy implemented by Cameron et al. (2011).
As robustness check, we also use the OLS fixed effects estimator with panel-corrected standard
errors (PCSE) based on the work by Beck and Katz (1995). It estimates the parameters by
OLS and estimates the standard errors and the variance-covariance matrix assuming that the
disturbances are by default heteroskedastic and contemporaneously correlated across panels. We
also assumed that errors are first-order auto correlated and that the coefficient of the AR(1)
process is specific to each panel.
3.5 Results
This section reports the main results of our analysis. In Section 3.5.1 we show results from the
estimation of the effect of the smoking ban on the incidence of AMI hospitalizations using the
identification strategy presented in Section 3.4. Section 3.5.2 investigates the mechanisms that
lead to the observed reduction in the incidence of hospitalizations after the implementation of
the smoking ban. This analysis is conducted using survey data from the SHS and the SHP.
Finally, Section 3.5.3 reports the results of a number of robustness checks already discussed in
Section 3.4.1.
3.5.1 The effect of smoking ban on AMI
We start showing in Table 3.3 the estimates of the effect of the public smoking ban on the
incidence of AMI hospitalizations on total population and by sex.
Each column represents a different specification.
Specifically, Model A includes area and time fixed effects; Model B adds monthly data on area
specific unemployment rates; as a further robustness check, Model C includes area specific linear
time trends. Estimates are implemented at cantonal (first set of rows) and regional level (second
set of rows). Consistent with the graphical evidence in Figures 3.1 and 3.2 (that aggregate data
at national level), the table shows robust evidence of a reduction in the incidence of AMI mainly
for men. For women, instead, we have evidence of a small and slightly significant effect only in
the regional estimates. This result should not be surprising given the very low incidence of AMI
among the total women population (see Table 3.2).
The estimated reduction in the incidence of AMI is robust across all specifications. The
estimated effect only slightly decreases in size (but not significantly) when we include area
specific time trends. This reduction should be due to the effect of imposing the same linear
trend before and after the reform in each area (for this reason, from now on we will use Model
B as reference). Most importantly, estimates are larger in size—although not significantly— at
the regional level. In the total population, it corresponds to a monthly reduction of roughly one
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Table 3.3: Effect of public smoking ban on AMI incidence, by sex
A B C
Panel A: cantonal estimates
Total -0.869 *** -0.854 *** -0.795 **
(0.317) (0.328) (0.346)
Men -1.489 *** -1.495 *** -1.364 ***
(0.423) (0.430) (0.495)
Women -0.279 -0.252 -0.263
(0.426) (0.439) (0.443)
Obs. 2808 2808 2808
N 26 26 26
Panel B: regional estimates
Total -1.231 *** -1.216 *** -1.113 ***
(0.354) (0.339) (0.359)
Men -2.016 *** -2.020 *** -1.908 ***
(0.609) (0.599) (0.659)
Women -0.453 * -0.459 ** -0.373
(0.234) (0.233) (0.256)
Obs. 11448 11448 11448
N 106 106 106
Area & time f.e. X X X
Monthly unemployment X X
Area specific trends X
Notes: The table shows the coefficient on the effect of the public smoking ban on the incidence of AMI hospitalizations by
sex.
Standard errors are robust and clustered at canton and month level (two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
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AMI case every 100’000 inhabitants (so a reduction of about 1’000 cases per year in Switzerland).
Looking at the mean incidence reported in Table 3.2, the estimated coefficients correspond to
roughly 8–9% reduction in the incidence of AMI according to the cantonal estimates and 10–12%
reduction for the regions. This difference is not surprising since, as aforementioned, cantonal and
regional estimates weight the cantons differently. In particular, the cantonal estimates give the
same weight to small and big cantons, while in the regional estimates bigger cantons get more
weight since they are split in more regions. If the effect is homogeneous across the population the
two estimates should converge. However, since most of the smaller cantons implemented only a
mild regulation against smoking in public places (see Table 3.1), we might expect a smaller effect
on these cantons. This is confirmed by the results provided in Table 3.4, where we show larger
effects in cantons that implemented the more severe regulation, and by a further robustness
check in which we use population weights for the cantonal estimates.7 For this reason, in the
analysis that follows we only show results for the regions (estimates at cantonal level are always
very similar).
Table 3.4: Strictness of the law: mild vs. severe law
Total Men Women
Regional estimates
Mild -0.357 -0.552 -0.204
(0.609) (1.015) (0.508)
Severe -1.356 *** -2.257 *** -0.500 **
(0.323) (0.535) (0.207)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the public smoking ban on the incidence of AMI hospitalizations
using two dummies for the ban (severe and mild implementation) using model B as in Table 3.3. Standard errors are
robust and clustered at canton and month level (two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
Having assessed the impact of the public smoking ban on the total population, we investi-
gate the heterogeneity of our results across age (Table 3.5), income and education (Table 3.6)
subgroups. Table 3.5 shows the results for three different age groups, under 50, 50–65 and 66+.
7The results, available upon request, are larger than those reported in Table 3.3, and very close to the regional
estimates.
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Table 3.5: Effect of public smoking ban on AMI incidence, by age and sex
under 50 50–65 66+
Regional estimates
Total -0.386 *** -1.879 ** -3.599 ***
(0.117) (0.907) (1.384)
Men -0.673 *** -4.263 *** -4.513 **
(0.238) (1.346) (2.032)
Women -0.105 0.495 -2.932 **
(0.075) (0.836) (1.412)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the public smoking ban on the incidence of AMI hospitalizations by
age and sex using model B as in Table 3.3. Standard errors are robust and clustered at canton and month level (two-way
clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
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Table 3.6: Heterogeneity by income and education
Low Income High Income Low Educ High Educ
Regional estimates
Total -1.875 *** -0.486 -1.470 *** -0.945 **
(0.512) (0.463) (0.396) (0.368)
Men -2.870 *** -1.198 -2.809 *** -0.822 **
(0.929) (0.783) (0.846) (0.298)
Women -0.911 *** 0.201 -0.169 -1.092
(0.272) (0.308) (0.518) (0.661)
Obs. 5724 5724 5724 5724
N 53 53 53 53
Notes: The table shows the coefficient on the effect of public smoking ban on the incidence of AMI hospitalizations by
education and income groups using model B as in Table 3.3. Standard errors are robust and clustered at canton and
month level (two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
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In absolute terms, larger effects are estimated in population subgroups more at risk of AMI,
namely men in the age group 50–65 and both men and women 66+. More specifically, for men
aged 50–65 and 66+ we observe a reduction in the incidence of about 5 cases every 100’000
inhabitants per month. Notice that for women, the effect in the age group more at risk of
AMI—women aged 66+—is now large and significant.
In relative terms, the story is quite different since for men the effect is larger for the subgroup
under 50 (20% reduction with respect to the mean incidence) and 50–65 (17%) . The difference
between absolute and relative terms is due to the difference in the risk of AMI across subgroups
but also to the different likelihood of each subgroup to attend bars and restaurants. In the next
section, using survey data from the SHP and the SHS, we show that younger people (under 66)
are more likely to go to bars and restaurants and were more exposed to ETS before of the policy
implementation.
The next step is to investigate whether the public smoking ban had a heterogeneous effect
across income and education groups. We argue that this analysis is particularly relevant from
a policy perspective since it concerns the potential impact of the policy on health inequality.
Indeed, a differential impact of the policy across socio-economic group would exacerbate (in the
case of a larger reduction among richer and high educated) or reduce the level of health inequality
in the incidence of AMI. Ideally, one should use individual data for this kind of analysis, but
the hospital register provides us only geographical information on patients’ residence. For this
reason, we implement the analysis at the smallest possible level of aggregation, the region. As
explained in Section 3.4, this level of aggregation allows us to exploit the within canton variation
in the level of income and education, and then control for institutional confounders at cantonal
level. In particular, using data on the average median income between 2004 and 2010, we split
the regions in two groups high vs. low income. We do the same for education using 2000
census data on education attainment. Table 3.6 clearly shows evidence of heterogeneity across
both dimensions, but in particular across income groups. It indicates that the effect of the ban
affected mainly low income and low education regions. In these regions, the estimated reduction
in AMI incidence is almost twice the average effect estimated in Table 3.3, while the reduction
in the richest and more educated regions is in most cases small and not statistically significant.
As for the previous evidence, in the next section we show that there was a clear SES gradient in
ETS exposure before the policy implementation that is able to explain our results.
Finally, we test whether the effect of the public smoking ban has been larger in cantons
that implemented the more severe regulation, as described in Section 3.2. We test this by
including in the regression two dummies that capture the effect of the two different regulations,
mild and severe. Table 3.4 shows the results by age. The table clearly indicates that the public
smoking ban had a significant impact on AMI only in regions where a more severe regulation was
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implemented. As previously discussed, mild regulation has been implemented mainly in smaller
cantons, also charachterized by the absence of metropolitan areas. On the other hand, we might
also expect that the public smoking ban had larger effects in metropolitan areas charachterized
by a large number of bars and restaurants. Therefore, we avoid speculating on the results
reported in Table 3.4, saying that mild regulation are not effective in reducing the incidence of
AMI hospitalizations.
3.5.2 How did the smoking ban reduce AMI incidence?
In the previous section we show evidence of a sharp and heterogeneous (by age and SES) reduction
in AMI hospitalizations after the implementation of the smoking ban. In this section we want
to investigate how this effect takes place. First, we want to figure out whether this effect comes
mainly from a reduction of smoking habits (both prevalence and cigarette consumption) and/or
a reduction in ETS. Second, we want to understand why the effect was larger among people
from low SES. Unfortunately, HOST data does not contain information on patient’s smoking
behaviors and on important socio-economic characteristics (i.e. income and education). We
overcome this problem by using data from two Swiss surveys, namely the SHS and the SHP. As
already discussed in Section 3.3, the SHS has been carried out every five years since 1992 and
provides important information on population health and health behaviors including smoking and
ETS. Using this dataset, Table 3.7 reports smoking prevalence, average cigarette consumption
and average (self-reported) minutes of ETS exposure by age and survey year.
In particular, we use the same age categories used in our main analysis and report statistics
for the survey years 2007 and 2012, namely the years before and after the implementation of
the smoking ban in public places across Switzerland. Consistent with most of the literature on
the effect of smoking bans on smoking habits (e.g. Anger et al. (2011); Jones et al. (2013)), the
table shows that between 2007 and 2012 there was no evidence of any reduction in smoking
prevalence and in smoking consumption. If ever, we observe a slight increase in consumption
among smokers aged 50+. At the same time, however, we observe a dramatic reduction in the
self-reported ETS over the 5 years for all age groups. The reduction is particularly large, more
than 50%, among people under 50 and people 50–65. The table also shows an age gradient in
both smoking prevalence and ETS. In effect, older people, especially those age 66+, smoke less
and are less exposed to ETS.8
The evidence reported in Table 3.7 is important for our analysis for two main reasons. First,
it reveals us that the reduction in AMI hospitalization should be due only to reduction in ETS
exposure and not to a reduction in smoking prevalence. Second, the evidence of an age gradient
8We checked whether this gradient is driven by the fact that there are more women among the older people.
However, even if we split the sample by both age and gender the gradient remains almost unaffected.
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Table 3.7: Smoking prevalence, cigarettes consumption and ETS exposure (minutes per day), by
age and survey year
Smokers Cig. per day ETS
2007 2012 2007 2012 2007 2012
under 50 31.39% 31.24% 9.35 10.00 38.40 16.54
(0.50) (0.49) (0.18) (0.20) (1.25) (0.91)
50–65 26.82% 26.18% 18.85 19.78 25.16 12.19
(0.66) (0.66) (0.32) (0.31) (1.27) (1.066)
66+ 11.37% 12.38% 25.14 27.80 9.42 6.07
(0.51) (0.55) (0.42) (0.40) (0.72) (0.65)
Notes: The first set of columns reports the percentage of smokers by age group in the survey years 2007 and 2012; the
second set of columns reports the average number of cigarettes smoked per day (conditional on smoking); while the third
set of columns reports the average self-reported minutes of ETS exposure per day. Data are extracted from the Swiss
Health Survey (2007 and 2012). Sample weights are used to take into account the sample design and non-response.
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in ETS exposure (and also in smoking prevalence) is consistent with the evidence reported in
the previous section. In particular, the smaller reduction in the incidence AMI hospitalization
—in relative terms— among people 66+ seems to be confirmed by the smaller exposure of this
age group to ETS. We argue that this is due to the lower probability of this age group to go out
in pub, bars and restaurants. We verify this hypothesis by using data from SHP that includes
in the questionnaire information regarding leisure activities, including pub, bar and restaurant
attendance. Using data from the 2007 wave of the SHP, Table 3.8 shows a clear age gradient
also in the likelihood of attending pubs, bars and restaurants.
Table 3.8: Going to bar, pub and restaurant, by age and sex
Men Women
weekly monthly weekly monthly
under 50 60.37% 89.87% 44.18% 83.38%
(0.36) (0.22) (0.33) (0.24)
50–65 54.55% 84.13% 40.17% 77.30%
(0.57) (0.42) (0.49) (0.42)
66+ 50.10% 76.58% 34.05% 65.44%
(0.76) (0.64) (0.61) (0.61)
Notes: This table shows the percentage of respondents that declare to go at least weekly or monthly in bar, pub and
restaurant by age and sex. Data are extracted from the 2007 wave of the Swiss Household Panel. Sample weights are used
to take into account the sample design and non-response.
Since statistics for 2012 are very similar, we prefer to split the sample also by sex. For both
men and women, the share of older people attending these public places at least weekly or monthly
is significantly lower than for the younger subgroups (under 50 and 50–65). Unfortunately the
survey does not allow to divide the attendance of restaurants from that of pub and bars, where
we might expect a larger exposure to ETS and a larger attendance of people under 50.
Finally, using the same approach, we investigate whether the socio-economic gradient in the
effect of the policy that we show in Table 3.6 can be explained by different levels of ETS expo-
sure across socio-economic groups. For this reason, in Table 3.9 we report smoking prevalence,
cigarette consumption and ETS by education and survey year.
We consider only two main education groups. The high educated group includes people with
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Table 3.9: Smoking prevalence, cigarettes consumption and ETS exposure (minutes per day), by
education and survey year
Smokers Cigarettes per day ETS
2007 2012 2007 2012 2007 2012
Low Educ 28.26% 29.53% 16.38 18.22 35.53 21.83
(0.41) (0.41) (0.25) (0.26) (0.92) (0.80)
High Educ 25.83% 25.47% 16.05 17.43 26.42 12.23
(0.60) (0.49) (0.38) (0.30) (1.02) (0.71)
Notes: The first set of columns reports the percentage of smokers by education in the survey years 2007 and 2012; the
second set of columns reports the average number of cigarettes smoked per day (conditional on smoking); while the third
set of columns reports the average self-reported minutes of ETS exposure per day. Data are extracted from the Swiss
Health Survey (2007 and 2012). Sample weights are used to take into account the sample design and non-response.
at least a high school diploma, while the low educated group includes people with vocational
education or below. As expected, smoking prevalence and especially ETS are larger among low
educated people in 2007. In effect, the average difference in ETS exposure is roughly 9 minutes.
This might explain why we found larger effects of the policy on people from low SES region.
Over the 5 years, the reduction in ETS exposure was dramatic for both education groups.
All in all, the results reported in this section are consistent with those reported in the previous
section and provide reasonable explanations and mechanisms for the estimated effect of the policy.
It is important to stress that even thought the evidence provided in this section is often based
on simple bivariate analysis, we are confident that they are not affected by composition effects.9
3.5.3 Robustness checks
In this section we implement a set of robustness checks as described in Section 3.4.1. The
first set of robustness checks are aimed to test the identification strategy of this paper. First
we implement what we call an “unconfoundedness test”, in which we test whether the policy
affected a set of health outcomes, namely the incidence of lung, prostate and breast cancer, that
should not be affected by the policy at least in the short run. The lung cancer affects both men
and women, while prostate and breast cancer are sex specific. Even though the lung cancer is
9We test it by running a set of multivariate regressions including all the observables characteristics (results are
provided upon request).
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affected by ETS, we should not be able to observe effects in the short term. This test is meant
to verify whether we are confounding the effect of the policy with some other unobservable trend
or confounder factors. The test reported in Table 3.10 shows no effect of the public smoking ban
on the incidence of all these health outcomes.
Table 3.10: Unconfoundness test: effect of the ban on the incidence of lung, prostate and breast
cancer
Lung cancer prostate cancer breast cancer
MS region estimates
Smoking Ban -0.002 0.002 -0.020
(.005) (.017) (.043)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the smoking ban using model B as in Table 3.3. Standard errors are
robust and clustered at canton and monthly level (two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
Second, we implement a sort of placebo tests to verify that there are no other jumps in the
AMI distribution before or after the real implementation of the policy. As argued by Carpenter
et al. (2011) this test is particularly suitable to test the endogeneity of the public policy because
it allows to control for one–year lead of the smoking ban. Table 3.11 shows the results of this
test.
The table clearly shows that there is no evidence of any significant discontinuity in the
distribution of the AMI hospitalizations before or after the real implementation.
Another robustness check that indirectly tests our identification strategy is to verify weather
the reduction in AMI hospitalizations was larger during the winter season, when people stay more
often inside the public place because of the adverse weather conditions. We show the results in
Table 3.12, where we report the average effect at the baseline (from April to October), and the
interaction with the winter season (from November to March).
As expected, the reduction in AMIs during the winter period is almost twice the reduction
we observe during the rest of the year (compare the size of the two coefficients). Again, the
results support our identification strategy.
The last robustness check concerns the estimations of the standard errors. As already dis-
cussed, to take into account the two potential sources of correlation, within (over time) and
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Table 3.11: Placebo test
Total Men Women
Regional estimates
1 year lag -.099 .098 -.304
(.514) (.902) (.371)
Smoking Ban -1.176 ** -1.981 ** -.382
(.470) (.839) (.303)
1 year lead .604 .722 .488
(.658) (.872) (.504)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the smoking ban using model B as in Table 3.3 and controlling for
the effect of two placebo reforms one year before and after the real implementation. Standard errors are robust and
clustered at canton and month level (two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
Table 3.12: Seasonal heterogeneity
Total Men Women
Regional estimates
Smoking ban -.822 ** -1.410 ** -.329
(.301) (.578) (.233)
Smoking ban*winter -.690 -1.177 ** -.104
(.428) (.508) (.660)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the smoking ban using model B as in Table 3.3 plus an interaction
term for the winter season (November to March). Standard errors are robust and clustered at canton and month level
(two-way clustering).
Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
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between regions, we use a two-way clustering strategy. As robustness check we use an OLS
fixed effects estimator with panel–corrected standard errors (PCSE). It estimates the variance-
covariance matrix assuming that the disturbances are by default heteroskedastic and contempo-
raneously correlated across panels, and it allows errors to be autocorrelated (first order auto-
correlation specific to each panel). Since this model estimates the full variance-covariance matrix
and so a very large number of time parameters (107), we avoid to include a full set of time fixed
effects. We substitute them with year and month fixed effects (18 parameters).
Table 3.13 shows that results from PCSE are very similar to those reported in the main text.
Table 3.13: Panel corrected standard errors estimates
Total Men Women
Regional estimates
Smoking ban -1.086 *** -1.815 *** -.380
(.394) (.626) (.385)
Obs. 11448 11448 11448
N 106 106 106
Notes: The table shows the coefficient on the effect of the smoking ban controlling for time and month fixed effects and
monthly unemployment rate. The effect is estimated using panel corrected standard errors assuming first order
autocorrelation, AR(1). Significance levels: ***p < 0.01, **p < 0.05, *p < 0.1.
3.6 Conclusion
In this paper we assess the causal effect of the introduction of public smoking bans in Switzerland
on AMI hospitalizations. We show that this anti-smoking policy implemented in Switzerland was
effective in reducing the cases of AMI. Our results are robust to different model specifications
and the large battery of tests implemented in this paper never casts doubt on our identification
strategy.
On average, the introduction of public smoking bans leads to a reduction of about 10-12% of
AMI hospitalization. However, we found large heterogeneity in the effect of interest across sex and
age groups. In absolute terms, we found evidence of larger reductions in AMI hospitalizations
among men 50+, the subgroup of the population with the largest incidence of AMI. Among
women, we found evidence of a significant reduction in AMI hospitalizations only in the age
group 66+, being them the only women subgroup really at risk of AMI. In relative terms, the
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largest reduction (roughly –20%) was observed among men under 50 and 50–65, the subgroups of
the population—among those at risk of AMI—that more often should go to bars and restaurant.
We also exploit the spatial heterogeneity in the effect of public smoking bans by focusing
our analysis on very small regions (spatial mobility regions), which allows us to hold constant
the confounding effect of institutional factors at cantonal level. Such analysis shows that the
policy was more effective in poorer and less educated regions and in regions that implement a
more severe regulation. The validity of our results is also supported by the available survey data
information on smoking prevalence, cigarette consumption and ETS.
Our analysis is of particular relevance from a policy perspective for at least two important
reasons. First, from a public health perspective, our paper shows that improving the quality of air
in public places through smoking bans has a positive impact on population health. Additionally,
our results demonstrate that the impact of the public smoking ban is even more effective in the
areas with low income and low education. In these areas the AMIs’ reduction is almost twice as
large as the average effect.
We also present evidence from survey data that support our results. In particular, we show
that younger and less educated people were more affected by ETS before the implementation of
the policy and so more likely to be affected by the policy. This is also supported by the large
drop in self-reported ETS exposure between 2007 and 2012 based on the data from the SHS.
Considering the well-know positive correlation between health, income and education, our results
suggest that such a public health intervention might also be able to reduce inequalities in health.
Secondly, this policy leads to a significant reduction of health related costs. In the USA, the
American Hearth Association (Go et al., 2014) estimates for 2010 a total cost of 204.4 billions
dollars due to hearth diseases. Even in Switzerland, the second country in the world for life
expectancy at birth (OECD, 2013), AMI is the leading cause of death and it represents a huge
economic burden. For instance, Wieser et al. (2012) estimate that in 2008 the total direct costs
of acute coronary syndrome (of which AMIs represent more than 80% of the costs) were more
than 1 billion Swiss Francs. To this large cost we should add 500 millions of indirect costs due
to production losses. Therefore a reduction of 10–12% of AMI hospitalizations means saving at
least 150 millions per year.
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